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ABSTRACT OF THESIS 
 
 
 
INGESTION OF ENDOPHYTE-INFECTED TALL FESCUE SEED INDUCES 
PERIPHERAL VASOCONSTRICTION BUT DOES NOT AFFECT CYCLICITY IN 
NON-PREGNANT MARES, AND A POPULATION OF BIOGENIC AMINE 
RECEPTORS RELATIVE TO VASOCONSTRICTION IS IDENTIFIED 
 
Three experiments were conducted to explore the effect of fescue toxicosis on 
vasoconstriction and various parameters of the estrous cycle. In the experiment of 
Chapter 3, a 2x2 crossover experimental design with repeated measures was implemented 
to test whether the ingestion of endophyte-infected tall fescue seed would alter blood 
hormone concentrations of prolactin, progesterone, and estradiol, interovulatory intervals, 
and corpus luteum blood flow. Also, Doppler ultrasonography was used to assess whether 
palmar artery and palmar vein lumen diameter, area, circumference, and resistivity index 
could be altered by the ingestion of endophyte-infected tall fescue seed. Ingestion of 
endophyte-infected tall fescue seed significantly decreased palmar artery resistivity 
index, area, and circumference, and palmar artery and palmar vein lumen diameter, but 
did not alter interovulatory intervals, serum concentrations of prolactin, progesterone, 
estradiol, or corpus luteum blood flow. Experiments 1 and 2 from Chapter 4 profiled the 
dopaminergic, serotonergic, and α-adrenergic receptor types and subtypes, as expressed 
within the equine medial palmar artery, medial palmar vein, and uterine artery  
transcriptomes. Combined results from Chapters 3 & 4 imply that relative quantity of 
serotonergic receptor subtypes within a vessel may be related to with the severity of that 
vessel's vasoconstrictive response to endophyte-infected tall fescue.  
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CHAPTER ONE: Introduction 
 
"Fescue toxicosis" is the singular term describing a multitude of adverse 
physiological conditions afflicting several animal species which ingest endophyte 
(Neotyphodium coenophialum; Glenn et al., 1996) -infected (E+) tall fescue (Lolium 
arundinaceum). Tall fescue is a commonly utilized pasture forage in the Southeastern 
United States, with an estimated 700,000 horses maintained on tall fescue pasture (Ball et 
al., 2002). With a desirable advantage in its capability for hearty growth in adverse 
conditions, such as drought, high and low temperatures, ill-suited soil, and heavy grazing 
(Ball et al., 1987; Siegel et al., 1987;  Bacon, 1995), tall fescue is still heavily propagated 
today. Nevertheless, livestock ingesting E+ tall fescue can exhibit signs of an ergotism-
like toxicity, signs not seen when livestock ingest endophyte-free (E-) tall fescue. The 
endocrine action of E+ tall fescue causes late pregnant mares to exhibit well established 
signs, such as agalactia, decreased blood hormone concentrations of prolactin (PRL) and 
progesterone (P4), increased  blood hormone concentrations of estradiol (E2), increased 
gestational intervals, birth of dysmature foals, and increased foal and placental weights 
(Loch et al., 1987; Monroe et al., 1988; Putnam et al., 1991; McCann et al., 1992).  
Producers often fail to recognize problems with fescue toxicosis, however, as 
many of the signs are not overtly severe and have the potential to go undetected. This is 
especially true for horses, as many fescue toxicosis signs such as reduced heat tolerance, 
decreased growth rates, and decreased fertility are not consistently reported (Putnam et 
al., 1991; Aiken et al., 1993; Brendemuehl et al., 1994; Arns et al., 1997). In addition, 
inconsistent observations plague studies concerning even well known signs in horses, 
such as those observed in pregnant mares grazing E+ tall fescue, as the severity of signs 
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from will vary study to study (Loch et al., 1987; Monroe et al., 1988; Ireland et al., 1991; 
Putnam et al., 1991). Thus, a high rate of between-study variation coupled with the many 
signs of fescue toxicosis that are not overtly severe could result in a producer or 
veterinarian often misdiagnosing a fescue toxicosis related problem.  
Investigations into early reproductive efficiency in horses is one such area fraught 
with between-study variation. In 1988, Monroe et al. observed that when mares were 
rebred after experiencing gestational failure due to fescue toxicosis, if kept on E+ tall 
pasture, they were likely to exhibit decreased fertility when compared to their 
counterparts grazing E- tall fescue. However, Brendemuehl et al. (1994) found that while 
mares would exhibit increased interovulatory intervals, increased P4 concentrations, and 
a tendency for increased early embryonic death while ingesting E+ tall fescue, 60 day 
pregnancy rates did not differ between mares ingesting E+ and E- tall fescue. This 
variation is likely due to differences in animals, differences in time of year of the studies, 
and differences in ergot alkaloid concentrations between the studies. Although the former 
two causes of variation may depend on differences in experimental design, the latter 
variation source is an area which should be controlled in future studies in order to provide 
producers and veterinarians a sound basis for the recognition of potential problems due to 
fescue toxicosis.  
Between-study variability in ergot alkaloid concentration in treatment diets is a 
problem which has the potential to be remedied in present day studies. Ergot alkaloid 
measurement methods used within studies have increased in precision from quantitation 
of percent endophyte infection in E+ tall fescue via tandem mass spectrometry (Yates et 
al., 1985) to methods which identify specific ergot alkaloids – and the concentration of 
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those alkaloids – within the plant via high-performance liquid chromatography 
(Rottinghaus et al., 1991). An increase in the sensitivity of ergot alkaloid identification at 
the chemical level would concomitantly suggest a need for the determination of both 
minimal and maximal levels of ergot alkaloid in the diet required to elicit signs of fescue 
toxicosis within the horse. As of yet, attempts at the establishment of at least baseline 
levels have not been successful (Loch et al., 1987; Arns et al., 1997; Smith et al., 2009), 
leaving investigators with no reliable means of controlling between-study variability in 
ergot alkaloid concentration.  Efforts to improve repeatability and remove variation in 
fescue toxicosis research must therefore include a method of assessing baseline toxicity 
levels in animals ingesting E+ tall fescue.  
In short, future studies in fescue toxicosis require investigators to have a complete 
and well rounded knowledge of the history of fescue toxicosis, a thorough knowledge of 
ergot alkaloid identification methods, the endocrine mode of action of fescue toxicosis, 
and a definitive method of minimizing variation within studies. To date, review of the 
literature reveals inconsistencies in the reporting of the effects of E+ tall fescue on early 
reproductive efficiency and fertility in the horse (Monroe et al., 1988; Brendemuehl et al., 
1994; Arns et al., 1997). One source of variation between these studies was the 
concentration of ergot alkaloid within the diets of treated animals, and the establishment 
of toxicity through some baseline measurement. The objective of this thesis is to explore 
the effect of fescue toxicosis on certain parameters of the estrous cycle, including 
differences in interovulatory interval, serum concentrations of PRL, P4, and E2, and 
blood flow to the corpus luteum (CL), while simultaneously attempting to establish a 
model for assessing baseline levels of toxicity in treatment mares.    
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CHAPTER TWO: Literature Review 
 
 
The History of Ergotism and Its Relation to Fescue Toxicosis 
An ergot is a type of fungus which produces mycotoxins called alkaloids (Peraica 
et al., 1999). Ergotism, therefore, is the poisoning of an individual by an ergot, usually by 
the means of an ergot-infected plant. As far back as 1100 BC, authenticated reports 
indicate that ergot refined from rye (Scale cereale L.) was used in obstetrics as a method 
of controlling blood loss (Schiff, 2006). Effects of ergotism in humans are traceable 
throughout history (van Dongen and de Groot, 1995; Schiff, 2006), but it was not until 
the middle ages that ergotism would reach epidemic proportions. Ergotism in these 
epidemics struck in two different forms throughout the middle ages: convulsive and the 
gangrenous forms (Schiff, 2006). In cases where resolution would not occur, death would 
result, and ergot-related deaths across history range in the tens of thousands (van Dongen 
and de Groot, 1995; Schiff, 2006). Soon, however, it became known that a trek to St. 
Anthony’s parish could prevent death and alleviate the sufferer's symptoms, and the 
disease soon became known as St. Anthony's Fire (van Dongen and de Groot, 1995; 
Schiff, 2006; Strickland et al., 2011). Modern knowledge has revealed, however, that the 
changing geological locations (i.e. trekking to St. Anthony's parish for care) resulted in a 
removal of the causative agent of the affliction, which was mainly bread made from 
ergot-infected rye (Schiff, 2006).  
In 1597 A.D.  the causative agent of these ergotism epidemics was identified by 
scientists at Marburg University (Marburg, Germany), who discovered that ergotism 
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would appear soon after ergot (Claviceps purpurea ) infected rye was eaten (Schiff, 2006; 
Strickland et al., 2011). Despite a scientific understanding of ergotism, individuals 
suffering from ergotism may have thought themselves to be victims of witchcraft, and the 
Salem Witch Trials are cited as an instance where ergotism would neatly explain the 
signs of the supposed victims (Caporael, 1976). A lack of foodstuff regulations allowed 
ergotism epidemics to persist (Strickland et al., 2011), as epidemics of the convulsive 
form of ergotism were documented even as late as 1928 (Schiff, 2006). Today, ergotism 
outbreaks are more likely to develop on an individual basis, due to the overdose of an 
ergot based drug such as ergotamine (Strickland et al., 2011), or perhaps in developing 
countries due to individual farming practices and slack grain cleaning protocols (Peraica 
et al., 1999).  
St. Anthony's Fire is now a malady of the past, even though the possibility of such 
outbreaks among the human population still exists (Peraica et al., 1999). However, its 
containment to history has been accomplished mainly through stricter regulations placed 
on grains used for human food (Peraica et al., 1999; Strickland et al., 2011). This still 
leaves livestock managers and forage producers at a loss, as scientists have learned to 
refine ergot alkaloids and use them for medicinal purposes (Peraica et al., 1999; Schiff, 
2006; Strickland et al., 2011), but are unable to negate their effects while the ergot 
alkaloids remain in the forage. Attempts to remove the negative economic impact of 
fescue toxicosis while still producing a resilient forage therefore requires a thorough 
understanding of the alkaloids produced by the endophytic fungus Neotyphodium 
coenophialum, such as the natural sources, chemistry, analysis, absorption, metabolism, 
clearance, toxicodynamics, and physiological signs associated with fescue toxicosis. 
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The History of Tall Fescue and Fescue Toxicosis 
Originally a European grass introduced to the United states in the 1800's (Buckner 
et al., 1979), tall fescue (Lolium arundinaceum) was re-discovered on a Kentucky farm in 
Menifee County  in 1931 by Dr. E.N. Fergus (Ball et al., 1987; Bacon, 1995). After much 
testing at the University of Kentucky, the grass was released in 1943 with distinguishing 
characteristics that made the cultivar particularly hardy (Buckner et al., 1979). During the 
1940's and 1950's, the grass was promoted vigorously to a southeastern public in need of 
a grass hardy enough to withstand its harsh summers. Its reception, and subsequent 
widespread popularity, resulted in the official recognition of the Kentucky 31 (KY31) 
cultivar in 1972 (Fergus and Buckner, 1972). Presently, KY31 has been adapted for use 
in most of the southern United States, with current estimates suggesting that between 14 
and 19 million hectares are occupied by tall fescue (Bacon, 1995; Bouton, 2007; 
Hannaway et al., 2009).  
The characteristics which fueled its promotion have allowed the endophyte-
infected (E+) tall fescue cultivar to out compete endophyte-free (E-) cultivars of grass. 
Not long after the initial release of the grass, reports of a disease in cattle resembling 
ergotism began to appear (Cunningham, 1948; Ball et al., 1987; Strickland et al., 2011). 
As time went on, livestock grazing tall fescue pastures demonstrated adverse 
physiological signs (Strickland et al., 2011), yet no cause was identified, despite rigorous 
study (Bacon, 1995). Terms such as "summer slump," "summer syndrome," "fescue 
toxicity," and "fescue toxicosis," began to describe the signs observed by livestock 
producers. The first concise listing of physiological signs affecting cattle was in 1963 
(Jacobson et al., 1963), and although scientists were rapidly pursuing an ergot-related 
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component within tall fescue, the physiological agent(s) responsible for the signs had not 
yet been identified (Bacon, 1995). 
Not until 1973 did a breakthrough occur in fescue toxicosis research, when in 
northern Georgia scientists began isolating a number of species of fungi (Bacon, 1995). 
Studies on the grass revealed a fungus that was endophytic, Claviceps - related, and 
capable of producing several toxic ergot alkaloids (Bacon et al., 1975; Porter et al., 
1979). Cattle toxicity data was reported in 1980 (Hoveland et al., 1980), when cattle 
grazing E+ and E- pastures were found to have different physiological signs. The 
association between endophyte and fescue toxicity has been confirmed numerous times 
(Schmidt et al., 1982; Monroe et al., 1988; Gadberry et al., 2003), firmly establishing that 
E+ tall fescue is toxic to livestock. Later research garnered a name for the fungus, 
Acremonium coenophialum (Morgan-Jones and Gams, 1982) (now Neotyphodium 
coenophialum; Glenn et al., 1996).            
 
Neotyphodium coenophialum and Alkaloid Production 
Produced mainly from the Neotypodium or Claviceps genera of fungi, ergot 
alkaloids are a naturally occurring, diverse group of compounds (Evans, 2011). These 
compounds therefore generally fall into three groups, or classes of alkaloid: ergopeptines, 
lysergic acid derivatives, and clavines (Komarova and Tolkachev, 2001; Schardl et al., 
2006). Of these compounds, it seems that ergovaline –  of the ergopeptine class –  is the 
most physiologically active alkaloid (Evans, 2011; Strickland et al., 2011). However, it 
should be noted that the scientific community has not ascribed total responsibility for 
fescue toxicosis to ergovaline (Hill et al., 2001; Gadberry et al., 2003), as it is still not 
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clear whether or not it is one alkaloid, several alkaloids acting in harmony, or a specific 
combination of alkaloids that cause fescue toxicosis (Strickland et al., 2009). 
Furthermore, several theories such as additive effects, bioaccumulation, resistivity, or 
increased sensitivity, have yet to be explored in detail (Klotz et al., 2008, 2009). 
Nevertheless, when compared to alkaloids such as lysergic acid, ergovaline was not 
outperformed in producing an adverse physiological response (Klotz et al., 2007; 
Strickland et al., 2009).  
Levels of ergot alkaloid – particularly ergovaline – in treatment diets appear to 
offer more sources of scientific variation when assessing toxic potential. Concentrations 
of ergovaline are indeed maximal in the seed head of the plant (Smith et al., 2009), yet 
the sheath, leaf, and stem of the plant still contain ergovaline and other alkaloids (Fayrer-
Hosken et al., 2008). Similarly, while a pasture might be determined E+ or E-, 
concentrations of ergovaline within the total available forage can vary from as little as 
100 ppb to as much as 1171 ppb (Oliver et al., 1993; Breuhaus, 2003; Matthews et al., 
2005). Additionally, the concentration of alkaloid within an infected plant can vary based 
on conditions such as drought, fertilization rate, and growth stage (Belesky and Hill, 
1997; Fayrer-Hosken et al., 2008). Ultimately, for the equine farm manager, total ergot 
alkaloid ingested by the animal becomes important in assessing a management strategy, 
as strategies such as replanting, reseeding, herbicide treatments, or domperidone 
treatment, can dramatically increase the cost of management as herd size and farm size 
increase. However, a safe concentration of ergot alkaloid in tall fescue has not been 
established for either non-pregnant, pregnant, or growing horses, as a threshold 
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concentration of alkaloid needed to produce fescue toxicosis signs has not been 
established (Smith et al., 2009).  
 
Ergot Alkaloid Disruption of Hormonal Homeostasis 
Ergot alkaloids have an ergoline ring structure (Komarova and Tolkachev, 2001) 
with a molecular architecture similar to various biogenic amines, including dopamine, 
serotonin, norepinephrine, and epinephrine (Berde, 1980; Weber, 1980; Komarova and 
Tolkachev, 2001). This structural similarity allows them to bind to the biogenic amine 
(dopaminergic, serotonergic, and α-adrenergic) receptors (Porter and Thompson, 1992; 
Abney et al., 1993; Dyer, 1993; Oliver et al., 1993). As a result, endocrine responses, 
such as decreased circulating blood concentrations of prolactin and vasoconstriction are 
observed. The agonistic interaction of ergot alkaloids on dopaminergic, serotonergic, and 
α-adrenergic receptors has an endocrine impact which is observed across a wide range of 
biological systems and species (Strickland et al., 1992; Abney et al., 1993; Schmidt and 
Osborn, 1993; Cross, 2011), and warrants review.  
In cattle, the interaction of the ergot alkaloids of E+ tall fescue with α-adrenergic 
and serotinergic receptors causes a peripheral vasoconstriction. Several in vitro studies 
have confirmed that ergot alkaloids will induce a significant contractile response in 
bovine vasculature when compared to the contractile ability of epinephrine (Klotz et al., 
2007; Klotz et al., 2010) and serotonin (Dyer, 1993; Oliver et al., 1993). In addition, in 
vivo experiments have shown cattle to have a significant peripheral vasoconstriction 
when ingesting E+ tall fescue (Rhodes et al., 1991; Aiken et al., 2007; Aiken et al., 
2009). In vitro contractility assays using equine vasculature showed a significant ability 
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of ergot alkaloids to induce a contractile response when compared to various biogenic 
amine compounds (Abney et al., 1993; Klotz and McDowell, 2010). This result has been 
confirmed in vivo using Doppler ultrasound (Moore et al., 2008; McDowell et al., 2009). 
Of utmost importance for understanding the fescue toxicosis syndrome is the 
endocrine control of prolactin. Detailed reviews of prolactin control are available (Ben-
Jonathan et al., 1985; Benker et al., 1990), but a brief review will be given here. Prolactin 
is secreted from the lactotrophs of the anterior pituitary, where tonic inhibition by 
dopamine (released from the hypothalamus) regulates its release (Ben-Jonathan and 
Hnasko, 2001). Certain compounds – such as E2, cholecystokinin, and serotonin – have 
been shown to stimulate PRL, but this mode of action is mainly through an inhibition of 
dopamine secretion (Ben-Jonathan and Hnasko, 2001). Dopamine arrives at the anterior 
pituitary via the hypothalamic-hypophysial portal system, where it exerts inhibition of 
prolactin by interacting with the dopamine type-2 (D2) receptor of the lactotroph 
(Strickland et al., 1992). It is through interaction with this receptor that ergopeptines 
mediate inhibition of prolactin release. 
Historically, the endocrine hallmark of fescue toxicosis in several species has 
been the decrease in circulating blood concentrations of prolactin (Neal and Schmidt, 
1985; Bond and Bolt, 1986; Monroe et al., 1988; Gadberry et al., 2003). In late pregnant 
mares, the decrease in prolactin concentrations can be observed in as little as three days 
(McCann et al., 1992), while concentrations of prolactin in cattle will decline to near zero 
within assay detection limits (Parish et al., 2003b). In cattle and sheep, this decrease in 
prolactin causes a decrease in milk production (Burke et al., 2010), while horses and 
rabbits may exhibit a complete agalactia (Stidham et al., 1982; Monroe et al., 1988; Cross 
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et al., 1995). Administration of dopamine D2 receptor (DRD2) antagonists, such as 
domperidone, will alleviate agalactia in foaling mares  (Redmond et al., 1994; Jones et 
al., 2003), providing evidence that decreased milk production is caused by the agonistic 
action of ergot alkaloids on the D2 receptors of the lactotrophs of the anterior pituitary 
gland. 
Other endocrine effects are evident, especially in the mare, where the impact of 
E+ tall fescue has the most deleterious effect during late pregnancy. In a healthy mare not 
grazing tall fescue, concentrations of estrogens decrease steadily in the final four months 
of gestation leading up to parturition (Palme et al., 2001), and relaxin increases steadily 
from day 240 to foaling (Stewart and Stabenfeldt, 1981). Progestagens (primarily 5α - 
pregnanes) increase in the final four to six weeks of gestation before decreasing 
precipitously in the final days – or even hours – before parturition (Ousey, 2004). 
However, in mares grazing E+ tall fescue, progestagens and relaxin are significantly 
decreased, and estradiol is increased (Monroe et al., 1988; Ryan et al., 2001). These 
alterations could potentiate the prolonged gestation seen in horses, as the initiation of 
parturition is dependent upon the functional maturation of the fetal organs (Ousey et al., 
2000). Of particular concern are the organs of the hypothalamic – pituitary - adrenal axis. 
The progestagens which increase in the final four to six weeks of gestation are derived 
from pregnenolone, which is produced in high quantities by the fetal adrenal gland at this 
time (Ginther, 1992; Ousey et al., 2000; Ousey, 2004). Thus, the decreased progestagen 
concentrations observed in mares ingesting E+ tall fescue may indicate that the function 
of the fetal hypothalamic -pituitary-adrenal axis is impaired, and this impaired function 
may be the cause of the prolonged gestations observed in mares grazing E+ tall fescue. 
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Endocrine function may also be altered in non-pregnant mares and cows ingesting 
E+ tall fescue, but reports in the literature are inconsistent. Varying rates of pregnancy 
reduction have been reported in cows consuming E+ tall fescue (7.6%-39.2%) (Gay et al., 
1988; Brown et al., 1992). Others, however, have failed to reproduce this effect in both 
cows (Burke et al., 2001a) and heifers (Mahmood et al., 1994). Similarly, studies 
involving non-pregnant mares ingesting E+ tall fescue have been unclear concerning 
endocrine function alterations. One study found that while mares were ingesting E+ tall 
fescue, luteal phases were prolonged, while embryonic losses during the first 14-21 days 
of gestation were not different from mares grazing E- tall fescue (Brendemuehl et al., 
1994). However, another study found that mares grazing E+ tall fescue had progesterone 
concentrations during the luteal phase which were similar to mares receiving E- diets 
(Arns et al., 1997). Ultimately, the effect of ergot alkaloids on the endocrine function of 
non-pregnant mares and cows should be investigated further in order to elucidate the 
mechanism for these inconsistencies. 
 
The Physiological Signs of Fescue Toxicosis 
Signs of fescue toxicosis manifest themselves across several different species 
(Hoveland et al., 1980; Monroe et al., 1988; Rhodes et al., 1991; Settivari et al., 2009), 
both sexes (Monroe et al., 1988; Fayrer-Hosken et al., 2008), and in varying degrees 
depending on the season (Burke et al., 2001b). In addition, signs seem to segregate 
themselves in accordance with the endocrine alterations imposed upon the animal, as 
ergot alkaloids have been shown to act agonistically on dopaminergic, serotonergic, and 
α-adrenergic receptors (Strickland et al., 1992; Dyer, 1993). A thorough understanding of 
13 
 
the manifestations observed when animals ingest E+ tall fescue will help understand the 
biology of this syndrome. 
 
"Summer Slump" is Heat Stress and Vasoconstriction 
During summer months, many observed problems caused by the ingestion of E+ 
tall fescue are termed "summer slump" (Schmidt and Osborn, 1993). Summer slump is 
associated with increased rectal temperatures, increased respiratory and heart rates, 
excessive salivation, and decreased average daily gain (ADG)  in cattle (Jacobson et al., 
1963; Rhodes et al., 1991), while lambs displayed varying rates of increased rectal 
temperatures (Aldrich et al., 1993; Gadberry et al., 2003) depending on the study. 
Increased rectal temperatures in affected animals are coupled with observed behaviors 
such as seeking shade and watering holes to cool themselves (Hemken et al., 1979; Bond 
et al., 1984; Rhodes et al., 1991). Recently, vasoconstriction has been posited as a causal 
link to "summer slump" due to the action of ergot alkaloids on α-adrenergic and 
serotonergic receptors (Dyer, 1993; Strickland et al., 2009; Foote et al., 2011; Strickland 
et al., 2011). A decrease in the ability of the individual to dissipate heat away from the 
body (due to vasoconstriction) would exacerbate the heat stress experienced during the 
warm months of the year (Burke et al., 2001b). Vasoconstriction therefore results in an 
inability of that individual to adequately thermoregulate, resulting in the signs of summer 
slump. 
Decreased ADG is another aspect of summer slump that may be exacerbated by 
heat stress due to excessive vasoconstriction during summer months. Cattle may exhibit 
decreased feed intake when consuming E+ tall fescue, but only when ambient 
14 
 
temperatures are in excess of 32 ⁰C (Burke et al., 2001b), an effect which is similar in 
mice (Larson et al., 1994). Lambs may exhibit up to 66% lower than normal weight gain 
when fed E+ tall fescue (Parish et al., 2003a), and feed intake is lower under heat-stress 
conditions (Rhodes et al., 1991). In livestock, the inability of an individual to cool itself 
predisposes it to decreased grazing during the day due to excessive shade seeking, and 
therefore decreased ADG (Aldrich et al., 1993; Thompson and Stuedemann, 1993). Still, 
other studies have not noted a temperature-dependent decrease in ADG (Boling et al., 
1984), allowing for other speculation as to a causal link of the decrease in ADG 
(Thompson and Stuedemann, 1993).  
Horses  do not display the signs that are attributed to summer slump (Cross et al., 
1995). Yearling geldings had decreased weight gains when fed E+ tall fescue (Aiken et 
al., 1993), but weight change was not seen in mature geldings (Redmond et al., 1991b) or 
mares (Monroe et al., 1988; Arns et al., 1997). Increased ease in sweating – and therefore 
cooling – is one of the proposed reasons why this sign is not observed in the horse 
(Putnam et al., 1991; Cross et al., 1995). Indeed, horses injected with intravenous ergot 
alkaloid exhibited increased sweating (Bony et al., 2001). As sweating is the primary 
means of heat dissipation in the horse (Scott et al., 2001), increased sweating while 
consuming E+ tall fescue may mitigate observations of summer slump in horses. 
Nevertheless, an alternative explanation for the mitigation of summer slump in horses 
may exist, as other studies have not observed increased sweating in horses ingesting E+ 
tall fescue (Webb et al., 2008; Parks, 2009).  
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"Fescue Foot" is Cold Stress and Vasoconstriction 
A more striking clinical sign observed in livestock grazing E+ tall fescue is 
"fescue foot" (Garner and Cornell, 1978). This is commonly observed in cattle and sheep 
(Tor-Agbidye et al., 2001), and is associated with a dull hair coat, loss of tail switch, 
lameness, gangrenous tissue, and sloughing of the hoof and tips of ears, with extreme 
cases resulting in loss of the whole limb (Garner and Cornell, 1978; Schmidt and Osborn, 
1993; Tor-Agbidye et al., 2001). Given the proper conditions – such as high alkaloid 
content of the pasture – livestock can become lame very quickly in cold weather. Cattle 
can become lame in as little as 18 days (Jensen et al., 1956), and sheep in 21 days (Tor-
Agbidye et al., 2001). Sloughing of the hoof is commonly preceded by the formation of 
lesions above the coronary band. During the late fall/early winter season, the ingestion of 
E+ tall fescue hay can elicit lesions in as little as six weeks, with the tissue below the 
lesions eventually becoming gangrenous and sloughing of tissue occurs (Jensen et al., 
1956). 
Fescue foot was once simply hypothesized to have been caused by a peripheral 
vasoconstriction (Jensen et al., 1956; Yates et al., 1979). It was known that livestock 
ingesting E+ tall fescue and suffering from fescue foot exhibit blood vessels of the hoof 
which were congested, affected with thrombosis, and thickened cell walls and constricted 
lumens (Jensen et al., 1956), however no direct cause could be confirmed. Recent studies, 
however, have demonstrated a unique vasoconstrictive potential of the alkaloids 
produced by Neotyphodium coenophialum (Klotz et al., 2007; Strickland et al., 2009; 
Foote et al., 2011; Klotz et al., 2010; Klotz et al., 2011). Thus the vasoconstriction which 
occurs during cold weather in order to conserve body heat (Curtis, 1983), combined with 
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the vasoconstriction caused by the ergot alkaloids, can produce an excessive peripheral 
vasoconstriction resulting in fescue foot.   
Horses, unlike sheep and cattle, do not exhibit the sloughing of any peripheral 
tissue, and fescue foot is not seen in horses grazing E+ tall fescue (Cross et al., 1995). It 
has been hypothesized that the incidence of laminitis will be increased in areas with the 
confirmed presence of E+ tall fescue (Rohrbach et al., 1995), however, studies 
elucidating other effects to E+ tall fescue on the horse have noted that laminitis was not 
an issue in treatment horses (Monroe et al., 1988; Putnam et al., 1991; Brendemuehl et 
al., 1994). Nevertheless, equine peripheral vasculature has been shown in vitro to be 
vasoconstrictive when stimulated with ergot alkaloids (Abney et al., 1993; Klotz and 
McDowell, 2010), and studies with Doppler ultrasound have confirmed that  E+ tall 
fescue will indeed elicit a vasoconstrictive response in vivo (Moore et al., 2008; 
McDowell et al., 2009). Still, no direct evidence links laminitis and ingestion of E+ tall 
fescue. Additionally, carbohydrate overload during spring and summer exists as an 
alternative explanation for when there is a correlation between laminitis and E+ tall 
fescue consumption (Rohrbach et al., 1995; Johnson et al., 2010). Taken together, these 
data would indicate that while sound in theory, there is no causal link between laminitis 
and the ingestion of E+ tall fescue in the horse.  
 
Reproduction in the Late Pregnant Mare  
Reproductive effects incurred by late pregnant mares grazing E+ tall fescue are 
perhaps the best documented of all fescue toxicosis signs (Ball et al., 1987; Monroe et al., 
1988; Putnam et al., 1991), as they are quite severe and not exhibited by other livestock 
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species. Prolonged gestation is well documented, with mares consuming E+ tall fescue 
prolonging gestation by 20-27 days (Monroe et al., 1988; Putnam et al., 1991; Redmond 
et al., 1994). This is likely the result of ergot alkaloid interference with a cascade of 
hormones, rather than with any one hormone alone. Mares suffering with prolonged 
gestation due to ingestion of E+ tall fescue often give birth to foals who are referred to as 
dysmature (Porter and Thompson, 1992), as they are carried past full term, abnormally 
large framed, and yet exhibit signs of being premature. Additionally, dysmature foals 
typically have poor muscling, long, fine coats, overgrown hooves, and irregular incisors. 
These large framed foals may be rotated 90 to 180 degrees from the normal dorsal-sacral 
presentation at parturition (Monroe et al., 1988; Porter and Thompson, 1992). Dysmature 
foals are thus captured in a parturition event for which neither they nor the maternal 
uterine environment is prepared. As such, up to 91% of mares grazing E+ tall fescue 
pastures may experience a dystocia, with only one out of 11 foals surviving past birth 
(Putnam et al., 1991).  
Dystocia – or difficult births – can produce a range of ill consequences, ranging 
from cervical tears to death. Mares grazing E+ tall fescue during gestation often have 
placentas which are thickened, red in appearance, and retained longer compared to mares 
grazing E- tall fescue (Monroe et al., 1988). This form of dystocia is colloquially referred 
to as a "red bag" delivery due to the reddish hue observed of the placenta when it is 
expelled (Cross et al., 1995). In a normal parturition, the placenta (chorioallantois) is 
breached at the cervical star, then expelled inside-out after the fetus has been delivered 
(Ginther, 1992), revealing a shiny interior. However, in cases of fescue toxicosis in 
pregnant mares, the microcotyledon/microcaruncle unit of the chorioallantois 
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prematurely separates, and the placenta does not rupture as the fetus is expelled (Cross, 
2011), and the blood-filled microcotyledon tufts give the placenta a red color. As such, 
red bag foals are often still encapsulated by the placenta after expulsion from the uterus 
(Cross, 2011). The resulting individuals have often been asphyxiated by the placenta and 
may succumb, only surviving with intensive human intervention. However, even with 
human intervention these foals are typically known to be unproductive.  
Pregnant mares suffering from fescue toxicosis lack normal mammary gland 
development, and often exhibit decreased milk production – or a complete agalactia – 
post-parturition (Cross, 2011). Lack of mammary development before parturition is of 
principle concern to farm managers, as normal mares (e.g., mares not grazing E+ tall 
fescue) will have noticeable mammary gland development three to six weeks before 
parturition (Ginther, 1992), indicating to the farm manager the need for increased 
observation. The lack of mammary development before parturition poses two problems to 
the farm manager. Of primary concern is the death of both mare and foal due to lack of 
proper observation at foaling. Indeed, it has been noted that most foals born to mares 
grazing E+ tall fescue will die (Putnam et al., 1991), and many of those parturition events 
will result in the death of the mare as well (Monroe et al., 1988; Putnam et al., 1991). 
However, if both mare and foal survive the parturition event, the next concern is of 
proper passive immunity passed to the foal through the mother's colostrum (Ginther, 
1992). The same hormonal cascade that affects parturition (Ginther, 1992) also affects 
lactogenesis and galactopoesis (Freeman et al., 2000), and is interfered with when mares 
are grazing E+ tall fescue. The result of this agalactia is an insufficient supply of 
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colostrum, leaving the newborn foal with an increased susceptibility to disease due to 
lack of passive immunity transfer.    
 
Fertility and Cyclicity   
In livestock grazing E+ tall fescue, both fertility and early gestation have been 
problematic as well. Calving rates were decreased from 96% to 55% when cows grazed 
E+ tall fescue (Schmidt et al., 1986). A three year study revealed a similar observation, as 
cows grazing E- tall fescue exhibited a 94.6% calving rate vs. a 55.4% calving rate for 
cows grazing E+ tall fescue (Gay et al., 1988). Investigations into the cause of decreased 
pregnancy rates revealed that although heifers were cycling normally, corpus luteum 
(CL) function may have been impaired. Evaluation of corpora lutea from cycling heifers 
who had grazed E+ tall fescue pasture for 56 days revealed that large luteal cell number 
and the number of mitochondria within these cells were increased compared to corpora 
lutea from heifers grazing E- tall fescue (Ahmed et al., 1990). A further complication is 
involved when considering heat stress. Although heat stress alone may cause reduced 
diameter of the CL and reduced P4 when compared to thermoneutral conditions, the 
interaction of heat stress and E+ tall fescue compared to E- tall fescue significantly 
reduced P4 and the diameter of the dominant preovulatory follicle to a greater extent than 
heat stress alone (Burke et al., 2001b).  
Horses may also have decreased fertility and early reproductive efficiency when 
grazing E+ tall fescue. Monroe et al. (1988) observed that gravid mares ingesting E+ tall 
fescue exhibited prolonged gestation, agalactia, dystocia, and the death of several foals. 
In addition, when the same mares were re-bred after parturition, mares still grazing E+ 
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tall fescue pasture exhibited decreased pregnancy rates compared to mares still grazing E- 
tall fescue. However, Brendemuehl et al. (1994) found no differences in 60-day 
pregnancy rates between mares grazing E- and E+ tall fescue, although mares grazing E+ 
tall fescue exhibited increased interovulatory intervals, increased progesterone levels, and 
a tendency for increased early embryonic death. Subsequently, Arns et al. (1997) reported 
no differences between mares ingesting E+ and E- tall fescue seed, and suggested that 
one source of variability among the experiments may have been concentration of ergot 
alkaloid in treatment diets.  
The effect of fescue toxicosis on early reproductive efficiency in horses is an area 
that may be of concern. As previously mentioned, many of the signs of fescue toxicosis 
may not be overtly severe, going undetected or being mistaken by producers, managers, 
and veterinarians (Strickland et al., 2011). However, with an economic impact of $102 
billion dollars annually (American Horse Council Foundation, 2005), and with the many 
advances made in equine reproduction (McKinnon et al., 2011), any effect of fescue 
toxicosis on early reproductive efficiency in the horse could be costly to ignore. Current 
research in this area is not conclusive, which anecdotally allows many to still maintain 
that E+ tall fescue is a good forage for all horses except gravid mares.    
  
Between-study Endophyte Variation: A Problem With A Solution 
Before the commencement of a study, investigators should take care to identify 
sources of variation from previous studies. Fescue toxicosis trials can be challenging, as a 
collaboration among chemists, plant scientists, and animal scientists is often required. 
Thus the application of new findings – such as realizations of between-study variation or 
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advancements in methodology – may not be immediately applied to a new experiment. 
Between-study variations can include the obvious differences of species and breed, as 
well as the less obvious differences in method of delivery of ergot alkaloid, concentration 
of ergot alkaloids animals are exposed to, concentration of additional ergot alkaloids in 
the diet (if ergovaline is the primary ergot alkaloid), and differences between laboratory 
analyses of ergot alkaloid concentrations.  
Within experiments, a homogenous population of animals may be desirable in 
elucidating the signs of fescue toxicosis that are not overtly severe, with special care 
taken to note that the concentration of ergot alkaloid required to reach toxicity is different 
for each species. Lambs have been shown to be susceptible to fescue toxicosis when 
ergovaline was present at a concentration of 640 μg ergovaline/kg total diet (Gadberry et 
al., 2003), while cows can be susceptible to fescue toxicosis when ergovaline is present 
130-190 μg ergovaline/kg total diet (Mizinga et al., 1992; Burke et al., 2001b). A 
minimum concentration of alkaloids resulting in fescue toxicosis in horses has not been 
established, but gravid mares showed signs of fescue toxicosis when ergovaline was 
present at a concentration of 390 μg ergovaline/kg total diet (Putnam et al., 1991), while 
non-pregnant mares may exhibit altered interovulatory intervals and early embryonic 
death when ergovaline is present at a concentration of 1171 ng ergovaline/g fresh weight 
grass (Brendemuehl et al., 1994). Similarly, while breed data within species is not 
available for either lambs or horses, data in cattle suggests a difference in fescue toxicosis 
susceptibility between Angus and Romosinuano breeds (Burke et al., 2010). 
With between species susceptibility to ergot alkaloids reaching orders of 
magnitude in difference, investigators must be certain that each treatment animal is 
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ingesting a precise amount of ergot alkaloid. Differences of method of delivery (injection, 
dry seed, or wet grass pasture) (Browning et al., 1998; Burke et al., 2001a; Burke et al., 
2001b), amount of ergot alkaloid exposure (Brendemuehl et al., 1994; Arns et al., 1997), 
concentration of secondary ergot alkaloid in the diet (if ergovaline is considered to be the 
primary ergot alkaloid) (Klotz et al., 2008,2010; Foote et al., 2011), and differences 
between lab analyses of ergot alkaloid concentration (Yates et al., 1985; Rottinghaus et 
al., 1991; Craig et al., 1994) could result in experimental animals receiving unknown 
amounts of ergot alkaloids. Most of these parameters have the potential for wide 
variation, and should be as similar as possible within and between studies. Of particular 
concern are differences in laboratory analyses, which in some cases differ in orders of 
magnitude, ergot alkaloids isolated, and at times repeatability (K. J. McDowell, Personal 
Communication).  
Given such tremendous sources of variation, a need for a standardized method of 
toxicity determination has arisen. Such a method would go beyond measurement of ergot 
alkaloid intake in treatment animals by providing real-time data on individual 
physiological responses to ergot alkaloid ingestion. Early reports observed that ergot 
alkaloids produced a vasoconstriction in vitro in equine vasculature (Abney et al., 1993; 
Klotz and McDowell, 2010); vasoconstriction has also been observed in vivo in cows 
using Doppler ultrasound (Aiken et al., 2007). Recently, a model published from this lab 
(Moore et al., 2008; McDowell et al., 2009) demonstrated that horses fed ground E+ tall 
fescue seed exhibited a marked decrease in diameter, area, and circumference of the left 
palmar artery, as measured by Doppler ultrasound. This model – dubbed the McDowell 
Model –may be able to provide investigators with a satisfactory bioassay for real-time 
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measurement of signs fescue toxicosis in an individual exposed to E+ tall fescue. Use of 
the McDowell Model may allow future researchers to establish standards for baseline 
toxicity in equine fescue toxicosis research. 
 
Summary  
Estrous cycle manipulation and tracking is an important facet of the equine 
breeding industry, with the incorrect prediction of an individual mare's ovulation costing 
the producer valuable time within the breeding season. Equine reproduction is an area of 
tremendous economic concern, but previous studies on the effect of E+ tall fescue on 
equine fertility and cyclicity have been inconclusive. An assessment of the literature 
reveals that current methods of determining fescue toxicosis in horses are insufficient, as 
even baseline levels of toxic intake have not been established. Attempts at conclusive 
investigation into the effect of E+ tall fescue on equine early reproductive efficiency must 
include satisfactory determinations of toxicity levels in treatment animals through a real-
time bioassay. A recent approach to the establishment of a real-time measurement of the 
premonitory signs fescue toxicosis has been the McDowell Model, which measures the 
established vasoconstrictive response to E+ tall fescue using Doppler ultrasound. The 
objective of this thesis is to explore the effect of fescue toxicosis on certain parameters of 
the estrous cycle, including differences in interovulatory interval, serum concentrations of 
PRL, P4, and E2, and blood flow to the CL, while simultaneously using the McDowell 
Model to assess levels of toxicity in treatment mares.   
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CHAPTER THREE: Ingestion of Endophyte-Infected Tall Fescue Seed Induces 
Peripheral Vasoconstriction but Does Not Affect Cyclicity in Non-Pregnant Mares 
 
Introduction 
After its discovery in 1931on a Menifee Co., KY farm, tall fescue (Lolium 
arundinaceum) was adapted for use as a forage with the distinguishing characteristics of 
dependability, resistance to grazing stress, and resistance to insect feeding (Buckner et 
al., 1979). These characteristics allowed this cultivar of tall fescue, now called Kentucky 
31 (KY31), to propagate very successfully across much of the Southeastern United 
States. Current estimates suggest that the KY31 cultivar of tall fescue occupies (or grows 
on) between 14 and 19 million hectares of land in the United States (Bacon, 1995; 
Bouton, 2007; Hannaway et al., 2009).  The hardiness of KY31 is due to a symbiotic 
relationship with an endophytic fungus Acremonium coenophialum (now Neotyphodium 
coenophialum) and the alkaloids it produces (Glenn et al., 1996). 
Although the symbiosis of N. coenophialum is beneficial to the tall fescue plant, 
the ergot alkaloids produced elicit detrimental health effects in horses and other livestock 
which ingest it. Late pregnant mares grazing endophyte infected (E+) tall fescue may 
suffer from prolonged gestation, altered hormone concentrations, agalactia and dystocia, 
and death of the mare and/or foal (Monroe et al., 1988; Redmond et al., 1991a). These 
detrimental health effects are reduced in severity – but not eliminated –with the 
administration of the dopaminergic D2 receptor (DRD2) antagonists (Redmond et al., 
1991a; Redmond et al., 1994; Jones et al., 2003). Thus, the ergot alkaloid agonism of 
DRD2 is thought to play a significant role in equine fescue toxicosis.  
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Although a small number of studies have been performed with equine fescue 
toxicosis on cyclicity and early reproduction in mares, the results have differed. 
Brendemuhl et al. (1994) reported prolonged luteal phases and increased plasma 
progesterone (P4) levels in non-pregnant mares grazing E+ tall fescue (1171 ng 
ergovaline/g wet grass). However, Arns et al. (1997) observed that serum concentrations 
of P4, luteal phase duration, and interovulatory intervals were not changed, concluding 
that the concentration of ergovaline (the primary ergopeptine ergot alkaloid in E+ tall 
fescue) in treatment diets (up to 308 μg ergovaline/kg total diet) was insufficient to 
produce any detrimental effects. Studies in other species involving the effects of E+ tall 
fescue on fertility and cyclicity suggest that this issue warrants further study. Cows 
grazing E+ tall fescue exhibited decreased pregnancy rates (Gay et al., 1988; Brown et 
al., 1992), while interovulatory intervals were increased (Seals et al., 1996). Decreased 
concentrations of prolactin (PRL) (Porter and Thompson, 1992) and P4 (Mahmood et al., 
1994) have also been reported in cattle grazing E+ tall fescue.  
One potential aid in determining the effects of E+ tall fescue on animal health is 
the establishment of a satisfactory in vivo bioassay capable of determining early signs of 
fescue toxicosis. Recent reports from this lab (McDowell et al., 2009; Moore et al., 2008) 
indicate that ingestion of E+ tall fescue seed causes a significant constriction of the 
palmar artery (PA) which is readily observed by Doppler ultrasonography.  Such reports 
are consistent with reports of vasoconstriction in cattle (Aiken et al., 2007). This model 
may be able to provide investigators with a satisfactory bioassay for determining the 
premonitory signs of fescue toxicosis in an individual exposed to E+ tall fescue.  
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The objective of this research study was to determine whether mares ingesting E+ 
tall fescue seed would exhibit altered interovulatory intervals, altered serum hormone 
concentrations, and altered blood flow to the corpus luteum (CL) compared to when the 
same mares were ingesting endophyte-free (E-) tall fescue seed. In addition, whether 
ingestion of E+ fescue seed caused constriction of the palmar vein (PV) as well as the PA 
was examined. The McDowell model of assessing vasoconstriction of the PA (Moore et 
al., 2008; McDowell et al., 2009) was used to observe the physiological signs of fescue 
toxicosis, allowing confirmation that the concentration of ergot alkaloids in the treatment 
diets was high enough to elicit a measurable biological response.  
 
Materials and Methods 
 
Animals 
Animal protocols were approved by the University of Kentucky Institutional 
Animal Care and Use Committee. This study was conducted from May through 
September, 2011, using 12 non-pregnant, normally cycling mares of mixed breed, 
ranging from age 4 to 20 years (with three older mares of unknown age used).  
 
Diet 
All mares were kept on low endophyte pasture (E+ tall fescue was 4% of 
available forage, with 19 μg ergovaline /kg available forage) and given ad libitum access 
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to water. Prior to the beginning of the experiment, mares were acclimated to the 
experimental diet over one interovulatory period. During this period, mares were 
acclimated to diet bulk with slowly increasing amounts of a grain mixture (Appendix A) 
until 0.3% of BW (average BW was 513 kg) was reached, and slowly increasing amounts 
of E- fescue seed (Kentucky 32 tall fescue seed) until 0.3% of BW was reached. Grain 
mixture and fescue seed were mixed together and top-dressed with molasses to increase 
palatability. During treatment periods, all mares were fed 0.3% of BW of either E+ or E-
fescue seed per day, with E+ fescue seed (Kentucky 31 tall fescue seed) containing 6.5 
mg total ergovaline (ergovaline + ergovalinine) per kg seed, and E- fescue seed 
containing undetectable levels of total ergovaline, as measured by high-performance 
liquid chromatography using the procedure of Yates (1988) as modified by Bush (Yates 
and Powell, 1988; Aiken et al., 2009). The E+ diet resulted in animals being fed 19.5 μg   
ergovaline + ergovalinine per kg BW, or an average of 10 mg per day. All seed was 
ground by passing it through a hammer mill prior to feeding. 
 
Experimental Design  
A 2x2 crossover experimental design with repeated measures was implemented, 
such that each period (P) of the 2x2 crossover was the duration of one estrous cycle (from 
ovulation, Day 0, to the next ovulation). A washout period was inserted between P1& P2, 
where Lutalyse (10mg) was given on Day 6 so that each mare's washout period lasted a 
minimum of 11 days (McCann et al., 1992). Mares were randomly assigned to a sequence 
of E+ E- or of E- E+ . Treatment E+ was defined as E+ fescue seed, while treatment E- 
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was defined as E- fescue seed, the control treatment. All mares were removed from 
treatment at the conclusion of P2 , and observed for 12 days before removal from the 
experiment.  
 
Data Collection  
For each mare in the study, the parameters of blood flow through the CL and 
blood vessel measurements were recorded. For PA and PV, diameter (mean of long and 
short diameters of the elliptical vessels), area, circumference and resistivity index (RI; 
calculated by (Peak Systolic Velocity - End Diastolic Velocity) / Peak Systolic Velocity ) 
were measured. Ultrasound images of the CL were recorded every other day, except for 
once per day around the time of ovulation. During these exams, images of CL blood flow 
were obtained using the Doppler Power setting on the ultrasound machine (Titan 
ultrasound, SonoSite Inc, Bothwell, WA, with a  L52/10-5 MHz linear array probe). 
Measurements of the PA and PV were assessed every fourth day, and on the day of 
ovulation, using the Pulsed Wave setting of the ultrasound machine (C11/8-5 MHz 
microconvex array probe).  Blood samples were collected via jugular venipuncture every 
other day, except for once per day around the time of ovulation. Blood samples were 
collected in non-heparinized tubes, and serum was separated by centrifugation and stored 
at -20 ⁰C for assay for PRL, P4, and estradiol (E2) (radioimmunoassays, courtesy of Dr. 
Don L. Thompson, Louisiana State University). Interovulatory interval was defined as the 
time interval (days) between observed ovulations, and each of these was recorded for 
future analysis of the effect of E+ tall fescue on interovulatory interval. Because not all 
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interovulatory intervals were the same, all data were truncated at day 16 after the first 
ovulation, then normalized to the second ovulation for analysis. 
 
CL Blood Flow Image Analysis 
Corpus luteum blood flow was assessed using images taken with the Titan 
ultrasound machine. During image capture, gray scale and color images were obtained on 
a vertical plane from the apex to the base of the CL, designated as the overall image, and 
area was assessed. After the animal work was completed, images were quantitatively 
analyzed using ImageJ, v 1.44, developed by the US National Institutes of Health 
(Rasband, 1997), to determine the area of the blood flow through the CL. Prior to image 
assessment, images were selected that contained no flash or color artifacts. If no such 
image was obtained, artifacts were removed from the image such that only color 
immediately surrounding the CL remained. After the image was loaded into ImageJ, the 
linear calibration was set for each image using the known distance scale given by the 
ultrasound. The color portion of the picture was then separated out by using the "HSU 
stack" option, stacking to images, and adjusting the threshold until only the region of 
interest was selected. Finally, blood flow area was reported using the "analyze particles" 
utility in ImageJ. A quantitative index of the relative amount of blood flow through the 
luteal tissue was created by taking the ratio of the colored area to a sectional plane at the 
maximum diameter of the CL, as previously described (Acosta et al., 2002). If two CLs 
were present, both ratios were added together such that the total area ratio was analyzed. 
Only total area ratios were included in the final analysis.  
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Statistical Analyses 
Interovulatory interval, peak serum concentrations of P4 (averaged over days 4- 
12 of each period), and number of days which P4 concentration was > 1ng/ml (days in 
diestrus) were analyzed as a two-period, two-treatment crossover design (Model 3.1, 
Appendix B). Blood vessel measurements (mean diameter, circumference, area, and RI of 
both the PA and PV), CL blood flow, and blood hormone concentrations (PRL, P4, and 
E2) were analyzed as a two-period, two-treatment crossover design with repeated 
measures. To more accurately reflect treatment differences at specific times within the 
estrous cycle, serum concentrations of PRL, P4, and E2 were analyzed for each period 
separately, and were combined across periods if period effects were not significant. In 
addition, serum concentrations of P4 were analyzed when concentrations were >1ng/ml, 
and serum concentrations of E2 were analyzed when P4<1ng/ml. The repeated measure 
of time was each measurement day in a treatment period. This model (Model 3.2, 
Appendix B) includes an analysis of sequence effect (E+ E- vs. E- E+). Because of the 
design, assumptions of no carryover effect and no treatment-by-period effect must be 
made, as the two terms are aliased with the sequence effect (Wallenstein and Fisher, 
1977). Therefore, a significant sequence effect will indicate a significant treatment-by-
period and carryover effect as well. If sequence effects were significant, then only data 
from P1 was considered for statistical inferences. All data were analyzed using the 
MIXED procedure of SAS (SAS Institute, 2010) v. 9.2, where effects were analyzed for 
significance using Fishers exact test. Individual tests for within day differences of means 
were analyzed using a two-sided t test for differences in least square means. 
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Results 
Two of the twelve mares did not ovulate during the last period of the experiment, 
one from each treatment group; therefore their data were dropped from the study. Outliers 
and leverage points were considered influential if their Cooks D values differed 
appreciably from the totality of the other values (Kuehl, 2000). Although influential 
observations may be physiologically normal, the frequency of data collection for this 
study is not in keeping with classical descriptive studies (Townson et al., 1989), thus the 
inclusion of influential observations in this data analysis may skew results. Three 
observations each were identified as influential leverage points and dropped from the 
analysis of serum PRL and serum E2. Results are summarized in Table 3.1 - Table 3.3. 
Palmar vein lumen diameter, circumference, and area had significant sequence effects. As 
such, only data from the analysis of P1 is presented for those parameters.  
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Table 3.1. Statistical analysis of the hormones prolactin (PRL), progesterone (P4), and 
estradiol (E2) for each period.a  
Parameter Effect P-Value Parameter Effect P-Value 
PRL  
  
P4 
   Treatment 0.0005  Treatment 0.1222 
 Period 0.0025  Period 0.4929 
 Sequence 0.2611  Sequence 0.1214 
 Time 0.0451  Time <0.0001 
 Period x Time 0.3223  Period x Time 0.9991 
 Sequence x Time 0.9795  Sequence x Time 0.9283 
 Treatment x Time 0.6978  Treatment x Time 0.9477 
   
   E2  
 
 
P4 > 1 
ng/ml  
  Treatment 0.5603  Treatment 0.1409 
 Period 0.2584  Period 0.3264 
 Sequence 0.1045  Sequence 0.1180 
 Time <0.0001  Time 0.0004 
 Period x Time 0.7599  Period x Time 0.9864 
 Sequence x Time 0.4309  Sequence x Time 0.9145 
 Treatment x Time 0.3443  Treatment x Time 0.7259 
   
   E2 
(P4<1ng/ml)  
 
P4 Peak 
 
  Treatment 0.9070  Treatment 0.0568 
 Period 0.9436  Period 0.8345 
 Sequence 0.1126  Sequence 0.0720 
 Time 0.0302  
   Period x Time 0.6394  
   Sequence x Time 0.9262  
   Treatment x Time 0.5289  
     
 
  a Blood hormone concentrations were additionally analyzed to more accurately reflect 
treatment differences at specific times within the estrous cycle, such that P4 was analyzed 
when P4 values were > 1 ng/ml, and E2 was analyzed when P4 values were < 1 ng/ml. 
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Table 3.2. Statistical analysis of the lumen diameter, circumference, area, and resistivity 
index (RI), for the palmar artery (PA), and palmar vein (PV).  
Parameter Effect P-Value Parameter Effect P-Value 
PA Lumen Diameter  PV Lumen Diameter  
 Treatment <0.0001  Treatment <0.0001 
 Period 0.2110  Time 0.1138 
 Sequence 0.0830  Treatment x Time 0.0493 
 Time 0.0352   
 Period x Time 0.8744 PV Circumference  
 Sequence x Time 0.5459  Treatment <0.0001 
 Treatment x Time 0.0063  Time 0.0723 
    Treatment x Time 0.1600 
PA Circumference     
 Treatment <0.0001 PV Area   
 Period 0.3814  Treatment <0.0001 
 Sequence 0.0567  Time 0.1966 
 Time 0.1647  Treatment x Time 0.3488 
 Period x Time 0.8003    
 Sequence x Time 0.6495 PV RI   
 Treatment x Time 0.0081  Treatment 0.2850 
    Period 0.3553 
PA Area    Sequence 0.4838 
 Treatment <0.0001  Time 0.7879 
 Period 0.2896  Period x Time 0.7298 
 Sequence 0.0825  Sequence x Time 0.4757 
 Time 0.1618  Treatment x Time 0.1082 
 Period x Time 0.7646    
 Sequence x Time 0.6015    
 Treatment x Time 0.0117    
      
PA RI      
 Treatment <0.0001    
 Period 0.1417    
 Sequence 0.7883    
 Time 0.0881    
 Period x Time 0.9210    
 Sequence x Time 0.7885    
 Treatment x Time 0.0087    
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Table 3.3. Statistical analysis of the corpus luteum (CL) blood flow (relative to CL area), 
interovulatory inverval (IOI), and number of days when progesterone (P4) was > 1 ng/ml. 
Parameter Effect P-Value 
CL Blood Flow (Relative to CL Area) 
 Treatment 0.0350 
 Period 0.1724 
 Sequence 0.6044 
 Time <0.0001 
 Period x Time 0.1529 
 Sequence x Time 0.4995 
 Treatment x Time 0.8103 
 
IOI 
  
 Treatment 0.1142 
 Period 0.876 
 Sequence 0.4436 
   Days When P4 
was > 1ng/ml   
 Treatment 0.2688 
 Period 0.083 
 Sequence 0.1518 
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Ingestion of E+ tall fescue seed caused significant decreases in PA and PV lumen 
diameters (Figures 3.1 and 3.2, respectively), and PA circumference, area, and RI over 
time, with only a tendency for significant sequence effects in these parameters. Once the 
sequence effect was taken into account, there were no significant treatment differences 
over time for the PV circumference, area, and RI. Treatment with E+ tall fescue seed 
decreased mean CL blood flow when compared to E- tall fescue seed, and CL blood flow 
was different by time (Table 3.3 and Figure 3.3). However, the treatment x time 
interaction indicated that there were no significant differences between treatments over 
time (Figure 3.4). In addition, when mares ingested E+ tall fescue seed, interovulatory 
intervals were not significantly altered (E+: 20. ± 0.4; E-: 19 ± 0.6) and the number of 
days when P4 was > 1 ng/ml were not significantly altered (E+: 12.6 ± 0.43; E-: 11.8 ± 
0.61).  
Analysis of serum concentrations of PRL treatment means showed that E- and E+ 
(6.09 ± 0.42 and 4.12 ± 0.31 ng/ml, respectively) treatment groups were different. Period 
and time effects were also significant when mares ingested E+ tall fescue seed. However, 
serum concentrations of PRL were not continually suppressed by treatment over time 
(Figure 3.5). Serum concentrations of P4 (Figure 3.6) and E2 (Figure 3.7) did not have 
significant treatment by time interactions, and means of P4 and E2 were not different 
between treatments. Additional analysis of serum concentrations of E2 when serum 
concentrations of P4 were < 1 ng/ml serum concentrations of P4 when concentrations of 
P4 were > 1 ng/ml revealed that there were no significant differences in treatment means, 
or between treatments over time. However, peak P4 values tended to increase when 
mares were fed E+ tall fescue. Review of the data suggested that this may have been 
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affected by mares who double ovulated during treatment periods. When mares that 
double ovulated were excluded from analysis, there was no effect of treatment on peak 
serum concentrations of P4 (Figure 3.7; P = 0.5524).  
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Figure 3.1. Comparison of palmar artery lumen diameters between treatments 
Palmar artery (PA) lumen diameter (cm; lsmean ± SEM) measured over the days of the 
estrous cycle. Since there was no period effect, P1 & P2 were combined. Treatments 
within the same day that have different letters are different (P < 0.05). 
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Figure 3.2. Comparison of palmar vein lumen diameters between treatments by period   
Palmar vein (PV) lumen diameter (cm; lsmean ± SEM) measured over the days of the 
estrous cycle. Since there was a significant period effect, and a significant sequence 
effect, P1 & P2 are displayed separately. Treatments within the same day that have 
different letters are different (P < 0.05). 
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Figure 3.3. Schematic of blood flow differences within one non-pregnant mare when 
ingesting endophyte-infected (E+) vs. endophyte-free (E-) tall fescue seed 
Frames A, B, and C represent the corpus luteum (CL) blood flow, palmar artery (PA) 
lumen diameter, and plamar vein (PV) lumen diameter (respectively) observed in one 
mare on Day 8 of her estrous cycle who had been ingesting E+ tall fescue seed since the 
beginning of that estrous cycle. Frames D, E, and F represent the CL blood flow, PA 
lumen diameter, and PV lumen diameter (respectively) observed within that same mare 
on Day 8 of her estrous cycle who had been ingesting E- tall fescue seed since the 
beginning of that estrous cycle. Total area ratios in frames A and D are 3.78 and 6.26, 
respectively. Short and long diameters for PA and PV were averaged together, and in 
frames B, C, E, and F, are 0.33 cm, 0.35 cm, 0.58 cm, and 0.45 cm, respectively.  
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Figure 3.4. Comparison of CL blood flow between treatments  
Corpus luteum (CL) blood flow (relative to CL area) (lsmean ± SEM) measured over the 
days of the estrous cycle. Since there was no period effect, P1 & P2 were combined. 
There was no  treatment x time interaction, so no within-day comparisons were made.  
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Figure 3.5. Comparison of serum concentrations of prolactin between treatments by 
period  
Serum concentrations of prolactin (PRL; ng/ml; lsmean ± SEM) measured over the days 
of the estrous cycle. Data collected during the acclimation period was averaged together 
and is shown as "PRE" on the graph. Since there was a significant period effect, P1 & P2 
are displayed separately. There was no treatment x time interaction, so no within-day 
comparisons were made.  
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Figure 3.6. Comparison of serum concentrations of progesterone between treatments.  
Progesterone (ng/ml; lsmean ± SEM) measured over the days of the estrous cycle. Since 
there was no period effect, P1 & P2 were combined. Data collected during the 
acclimation period was averaged together and is shown as "PRE" on the graph. There was 
no  treatment x time interaction, so no within-day comparisons were made. 
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Figure 3.7. Comparison of serum concentrations of estradiol between treatments.  
Estradiol (pg/ml; lsmean ± SEM) measured over the days of the estrous cycle. Since there 
was no period effect, P1 & P2 were combined. Data collected during the acclimation 
period was averaged together and is shown as "PRE" on the graph. There was no  
treatment x time interaction, so no within-day comparisons were made.  
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Figure 3.8. Peak serum progesterone (ng/ml; lsmean ± SEM) concentrations when mares 
that double ovulated were included or excluded. 
When peak serum progesterone concentrations included mares who double ovulated, 
treatment means for mares who consumed E+ tall fescue seed tended (P = 0.0568) to be 
increased compared to treatment means for mares who consumed E- tall fescue seed. 
However, when peak serum progesterone concentrations excluded mares who double 
ovulated, there was no difference in treatment means (P = 0.5524). 
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Discussion 
Effects of E+ tall fescue on non-pregnant mares have been hypothesized to 
include increased interovulatory interval, increased serum concentrations of P4, and 
decreased serum concentrations of PRL. These effects, however, are inconsistent, and are 
represented by conflicting reports in the literature (Monroe et al., 1988; Brendemuehl et 
al., 1994; Arns et al., 1997). While some suggest that the interovulatory interval, and 
therefore serum concentration of P4, is increased in mares grazing E+ tall fescue 
(Brendemuehl et al., 1994), others have failed to confirm this finding (Arns et al., 1997). 
A variety of deleterious early reproductive effects are observed when cattle graze E+ tall 
fescue (Bond and Bolt, 1986; Mahmood et al., 1994), including decreased pregnancy 
rates and increased interovulatory intervals (Seals et al., 1996). Although the 14 day 
viable pregnancy rates tended to be lower and early embryonic death rates tended to be 
higher in mares grazing E+ tall fescue, pregnancy rates after 60 day are not significantly 
different when comparing mares grazing E+ and E- tall fescue (Brendemuehl et al., 
1994). The objective of this current study was to elucidate the changes related to the 
estrous cycle in the non-pregnant mare ingesting E+ tall fescue.  
Mares ingesting E+ tall fescue seed did not exhibit decreased serum 
concentrations of PRL over time when compared to mares ingesting E- tall fescue seed. 
Additionally, when mares ingested E- tall fescue seed, mean serum concentrations of  
PRL for the non-pregnant mares in this study (6.09 ± 0.42 ng/ml) are similar to 
previously reported serum concentrations of PRL (7.0 ± 1.0 ng/ml) (Thompson et al., 
1986).  There was considerable within and between animal variability, as evidenced by 
the large standard errors associated with the PRL data.  In addition, PRL concentrations 
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in non-pregnant mares are considerably lower than in non-pregnant cattle (typically < 10 
ng/ml for mares (Johnson, 1986; King et al., 2008) and 100-200 ng/ml for cattle (Aiken et 
al., 2007; Aiken et al., 2009), and these lower values may make it more difficult to 
demonstrate a reduced concentration of PRL due to E+ fescue seed. Finally, serum PRL 
differs somewhat over the estrous cycle and with season in non-pregnant mares (Johnson, 
1986; King et al., 2008), and in these experiments not all mares consistently ate all of 
their ration, both of which might have added to the variability of PRL in these studies.  
Mean serum concentrations of PRL for non-pregnant mares may be different from 
serum concentrations of PRL in late pregnant mares grazing both E- (51.6 ± 4.50 ng/ml) 
and E+ (16.1 ± 3.81 ng/ml) tall fescue pastures (Monroe et al., 1988). When Monroe et 
al. (1988) reported PRL concentrations from pregnant mares in mid-gestation grazing E+ 
vs. E- pastures, the values reported for the E+ mares were similar to those reported here. 
This suggests that, in pregnant mares, instead of decreasing serum concentrations of PRL, 
the ingestion of E+ tall fescue suppresses the increase in serum concentrations of PRL 
that occurs in late gestation. Thus, a suppression of serum concentrations of PRL over 
time below normal serum concentrations in non-pregnant mares may be difficult. Other 
studies investigating the effects of E+ tall fescue on serum concentrations of PRL in non-
pregnant mares (Arns et al., 1997) found significant differences in serum concentrations 
of PRL between treatments. However, the differences in PRL observed by Arns et al. 
(1997) were not analyzed over time, as were the treatment differences in this study. This 
suggests that the differences reported by Arns et al. (1997) may have ignored the subtle 
daily changes of PRL through the estrous cycle. This hypothesis is supported by the 
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observation that, in this study, mean serum concentration of PRL did not differ over time, 
even though the overall means of the two treatments were different. 
Serum concentrations of E2 and P4 differed significantly over time (P < 0.0001 
and P < 0.0001, respectively), yet the cyclic nature of these hormones during the estrous 
cycle suggests that this is to be expected. Thus, the treatment x time interaction effect 
was used to reveal that the ingestion of E+ tall fescue seed did not significantly alter 
serum concentrations of P4 or E2. Still, the analysis of treatment effects suggested that 
the ingestion of E+ tall fescue seed tended to increase serum concentrations of P4 across 
each of the three methods of analyzing P4. However, the removal of mares who double 
ovulated nullified this tendency. These results differ from those reported by Brendemuehl 
et al. (1994), but agree with those reported by Arns et al. (1997). Data reported by 
Brendeuehl et al. (1994) suggested that the increase in serum concentrations of P4 were 
due to increased cycle lengths. Data reported by Arns et al. (1997), however, suggested 
that serum concentrations of P4 in mares grazing E+ tall fescue seed were not different 
from previously reported serum concentrations of P4 in mares grazing E- tall fescue. 
However, the mention of mares who double ovulated was not included by either of these 
studies. In this study, the removal of mares who double ovulated resulted in treatment 
effects which were not different.  This reveals the dynamic nature of hormones during the 
estrous cycle, and should be taken into account in future studies.  
Interovulatory intervals were unchanged over two cycles in mares ingesting E+ 
tall fescue seed. Thus, the lack of changes in P4 and interovulatory intervals do not agree 
with the results reported from Brendemuehl et al. (1994). This discrepancy could result 
from differences in ergot alkaloid concentration within treatment diets. Brendemuehl et 
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al. (1994) reported an ergovaline concentration of 1171 ppb in E+ tall fescue pastures, 
while Arns et al. (1997) reported a maximum of 308 ppb ergovaline concentration in their 
diets. Arns et al. (1997) also estimated that mares in the  that Brendemuehl study may 
have consumed close to 30 mg of ergovaline/day, while their own mares consumed only 
up to 2.8 mg ergovaline/day. In grazing studies, however, it is not possible to know the 
precise amount of forage consumed, and the alkaloid concentrations in the forages may 
change over time. 
Mares fed the treatment diet in this study were fed E+ tall fescue seed with a 
concentration of 6500 ppb total ergovaline (ergovaline + ergovalinine), giving an average 
consumption of 10 mg ergovaline/day. This amount is five times higher than that reported 
by Arns et al. (1997), but only one-third the amount potentially consumed in the 
Brendemuehl et al. (1994) study. The primary implication of this observation is that the 
1171 ng/g ergovaline in the pastures that are 90% endophyte infected in the Brendemuehl 
study may not represent typical pasture conditions on commercial horse farms. This 
concentration is over ten-fold higher than the concentrations fed by Arns et al. (1997) and 
three times higher than this study. Thus, it is possible that the concentration of ergovaline 
fed to treatment mares in this study was not high enough to elicit changes similar to those 
seen by Brendemuehl et al. (1994).  
Peripheral vasoconstriction in non-pregnant mares was significantly increased 
over time by the ingestion of E+ tall fescue seed, as measured by the PA and PV lumen 
diameter, and PA area, circumference, and RI. This agrees with and expands upon 
previous reports from this lab (Moore et al., 2008; McDowell et al., 2009), which only 
noted decreases in PA lumen diameter, area, and circumference when mares were fed E+ 
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tall fescue seed. As of yet, the vasoconstrictive effects of E+ tall fescue in horses have not 
been shown to produce the same deleterious effects seen in cattle (Porter and Thompson, 
1992; Strickland et al., 2011). However, the anatomical and physiological differences 
between horses and other species may allow the horse to overcome some of the 
detrimental effects of vasoconstriction induced by the ingestion of E+ tall fescue.  
Even at a lower concentration of ergovaline consumed by mares in this study 
(compared to those fed by Brendemuehl et al. (1994)), vasoconstriction still occurred. 
Thus, peripheral vasoconstriction may serve as a more sensitive indicator of a non-
pregnant mare's exposure to E+ tall fescue than serum concentrations of PRL. 
Furthermore, vasoconstriction of the PA may be a more sensitive indicator of a non-
pregnant mare's exposure to E+ tall fescue than vasoconstriction of the PV. The sequence 
effects in the PV lumen diameter, area, and circumference indicate that, rather than an 
insufficient washout period, mares ingesting E+ tall fescue seed during P2 did not 
respond in the same vasoconstrictive manner as mares ingesting E+ tall fescue seed 
during P1. In addition, the significant vasoconstrictive response observed in the PA 
indicates that the PV response is not due to an insufficient intake of E+ tall fescue seed, 
but could be related to other parameters not measured in this study. Thus, since sequence 
effects were not observed in any of the blood hormone, CL blood flow, or PA parameters 
measured, the response of the PV may need to be evaluated separately from other 
parameters during future in vivo research in order to account for and further describe this 
between subject variability.  
Further observations indicate that while non-pregnant mares may exhibit a 
decreased PA and PV lumen diameter when ingesting E+ tall fescue seed, those 
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vasoconstrictive effects may not extend internally to decrease CL blood flow over time. 
Still, studies investigating the vasculature of the CL in cows have observed that in the 
mid-cycle CL, an induction of luteolysis with PGF2α results in an immediate increase in 
blood flow followed by a decrease, an effect not seen in the early CL (Acosta et al., 
2002). Thus, the lack of vascular response seen in the early CL may contribute to its 
ability to be resistant to PGF2α. This may represent the mechanism by which mares in 
previous studies exhibited increased interovulatory intervals (Brendemuehl et al., 1994), 
as decreased blood flow to the CL in mares ingesting E+ tall fescue could result in a 
failure of the CL vasculature to respond appropriately to PGF2α. However, results from 
this study could not confirm this hypothesis. This indicates that the dramatic results 
observed by Brendemuehl et al. (1994) may have been due to the extremely high 
concentration of ergot alkaloid in treatment pastures which were mostly (90%) infested 
with E+ tall fescue.  
The results from this study suggest that, the lumen diameter of the PA and PV, 
and the PA RI, area, and circumference, are significantly decreased in non-pregnant 
mares ingesting E+ tall fescue seed. Meanwhile, interovulatory interval, number of days 
of diestrus, CL blood flow, serum concentrations of PRL, P4 and E2, and PV RI are not 
significantly affected by the ingestion of E+ tall fescue seed when mares are fed up to 10 
mg of total ergovaline per day. The vasoconstriction observed in the PA and PV suggests 
that Doppler ultrasound may be used as a tool to diagnose exposure to E+ tall fescue. 
Future studies are needed to further elucidate whether the differences in vasoconstriction 
between the PA and PV are directly correlated, and with an increased sample size further 
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elucidate the apparent between subject variability in the vasoconstrictive potential of the 
PV.   
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CHAPTER FOUR: A Population of Biogenic Amine Receptors With 
Vasoconstrictive Properties Exists in Isolated Equine Palmar Artery, Palmar Vein, 
and Uterine Artery Samples  
 
 
Introduction 
After its discovery on a 1931 Menifee Co., KY farm, tall fescue (Lolium 
arundinaceum) was promoted as a forage with the distinguishing characteristics of 
dependability, resistance to grazing stress, and resistance to insect feeding (Buckner et 
al., 1979). These characteristics allowed the KY31 cultivar of tall fescue to propagate 
very successfully across much of the Southeastern United States. Current estimates 
suggest that between 14 and 19 million hectares of land in the United States grow the 
KY31 cultivar of tall fescue (Bacon, 1995; Hannaway et al., 2009). Later research 
discovered the source of the hardiness of KY31 tall fescue to be the endophytic fungus 
Acremonium coenophialum (now Neotyphodium coenophialum; Glenn et al., 1996). 
Although the symbiosis with N. coenophialum is advantageous to tall fescue, the 
ergot alkaloids produced by the fungus cause a symptomology in the animals that 
consume it referred to as fescue toxicosis. Detrimental reproductive signs are seen in 
pregnant mares grazing endophyte-infected (E+) tall fescue, which can include death of 
both mare and foal (Monroe et al., 1988; Stidham et al., 1982). These signs are thought to 
be brought about in part by the binding of ergot alkaloids to dopaminergic receptors. This 
is supported by the alleviation – but not elimination – of negative reproductive effects in 
horses by the administration of type-2 dopaminergic receptor (DRD2) antagonists 
(Redmond et al., 1994; Jones et al., 2003).  
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Signs in other animal models – such as increased rectal temperatures, increased 
shade seeking, and sloughing of the hooves, tips of ears, and tips of tails – are the result 
of increased peripheral vasoconstriction due to the agonistic binding of ergot alkaloids to 
α-adrenergic and serotonergic receptors (Dyer, 1993; Oliver et al., 1998; Schöning et al., 
2001; Klotz et al., 2012). Similar signs caused by vasoconstriction have not been reported 
in horses grazing E+ tall fescue. Increased sweating in horses grazing E+ tall fescue has 
been observed and has been explained as a possible compensatory mechanism which 
allows the horse to overcome some of the detrimental vasoconstrictive effects of fescue 
toxicosis during periods of heat stress (Cross et al., 1995; Bony et al., 2001).  
Investigations have confirmed that ergot alkaloids found in E+ tall fescue will 
elicit a vasoconstrictive response in equine vasculature. In an in vitro study, Abney et al. 
(1993) used isolated equine lateral saphenous vein and dorsal metatarsal artery to 
compare the vasoconstrictive effects of various ergot alkaloids found in E+ tall fescue 
(ergotamine, ergonovine, and N-acetyl loline) to various biogenic amine compounds 
(norepinephrine, phenylephrine, BHT-920, and serotonin). This study demonstrated for 
the first time that ergot alkaloids were vasoactive in equine vasculature, although not as 
potent as the biogenic amine compounds, and was later confirmed by Klotz and 
McDowell (2010). Recently, an in vivo model of measuring vasoconstriction in the horse 
using Doppler ultrasound has been established (Moore et al., 2008; McDowell et al., 
2009). Horses ingesting E+ tall fescue seed exhibited a decreased diameter of the palmar 
artery compared to horses ingesting endophyte-free (E-) tall fescue seed, as measured by 
Doppler ultrasound (McDowell et al., 2009). Research currently underway also suggests 
that E+ tall fescue may elicit a vasoconstrictive response in uterine arteries, as pregnant 
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mares ingesting E+ tall fescue seed exhibited a vasoconstriction similar to that seen in the 
peripheral vasculature (McDowell et al., 2012). 
Although these studies provide strong evidence that E+ tall fescue elicits a 
vasoconstrictive response in equine vasculature, the specific mechanism of action of 
ergot alkaloids in the horse is still unknown. The agonistic action of ergot alkaloids on α-
adrenergic and serotonergic receptors produced a marked vasoconstriction described in 
species other than the equine, such as the bovine (Dyer, 1993; Klotz et al., 2010) and the 
ovine (Gadberry et al., 2003). While a constrictive effect has been observed in equine 
vasculature in response to ergot alkaloids, the exact profile of receptors which might be 
responsible for this response has not yet been determined. Knowledge of what receptors 
are present would help target future research in determining what receptors specifically 
interact with tall fescue alkaloids. Therefore, the purpose of this study was to profile the 
genes for dopaminergic, serotonergic, and α-adrenergic receptor types and subtypes, as 
expressed within the equine medial palmar artery (PA), medial palmar vein (PV), and 
uterine artery (UA) transcriptomes.  
 
Materials and Methods 
 
Animals and Tissue Collection 
Immediately after euthanasia, PA, PV, and UA were collected from 14 mixed 
breed mares in total. Forty vessels were collected. Additionally, heart, kidney, 
hypothalamus, and pituitary tissues were collected from one individual and pooled for 
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use as positive tissue control. Mares were euthanized over an 8 month period of time, and 
represent a cull population from the University of Kentucky Veterinary Science breeding 
population. After dissection, each vessel was cleaned of adipose and connective tissue, 
placed in an aluminum pouch, and snap frozen in liquid nitrogen. Blood vessels were 
stored in a -80 ⁰C freezer until RNA isolation. The experimental protocol was approved 
by the University of Kentucky Institutional Animal Care and Use Committee. 
 
Sample Preparation 
Isolation of RNA was completed using the TRIzol reagent (Invitrogen, Cat. No. 
15596-018) isolation protocol (Appendix C), and the RNeasy RNA cleanup kit 
(QIAGEN, Cat. No. 74104) protocol (Appendix D) was used to remove any carbohydrate 
and protein contamination from the RNA samples.  Concentration of RNA was verified 
using a Nanodrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Inc.), and 
quality was evaluated using an Experion RNA StdSens analysis kit (Bio-Rad laboratories 
Inc., Cat. No. 700-7106) procedure (Appendix E). Any RNA samples that were found to 
have DNA contamination were treated using the Ambion TURBO DNA-free DNase 
treatment and removal reagents (Applied Biosystems, Part No AM1907; Appendix F). 
The final purified RNA samples were used to make cDNA using the AccuScript High 
Fidelity 1st strand cDNA synthesis kit (Agilent Technologies, Cat. No. 200820) for 
reverse transcriptase-mediated polymerase chain reaction (Appendix G).  
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Primers 
Genes for specific subtypes of α-adrenergic, serotonergic, and dopaminergic 
receptors were chosen based on previous reports of expression in vascular tissue within 
The Sigma-RBI Handbook of Receptor Classification and Signal Transduction (SIGMA-
RBI, 2006). Equine-specific nucleotide sequences were obtained from previously 
published sequences in Genbank (National Center for Biotechnology Information, 
National Institutes of Health, Bethesda, MD), or by performing the Basic Local 
Alignment Search Tool (BLAST) of predicted equine sequence available in Genbank 
(Zhang et al., 2000). Sequences used for primer sets in Experiment 1 are shown in Table 
4.1; sequences used for primer sets in Experiment 2 are shown in Table 4.2. Primers were 
constructed using PrimerQuest (Integrated DNA Technologies). 
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Table 4.1. List of primers used to amplify equine-specific nucleotide sequences within isolated palmar artery, palmar vein, and uterine 
artery  vessels for Experiment 1.  
Receptor Gene ID # Accession Number Forward Primer Reverse Primer Location Annealing Temperature PCR Product (bp) 
Adrenergic        
α-1A 100054461 XM_001494586.2 
5'- AGT GTC TCC GCA 
GAA AGC AGT CTT -3' 
5'- TCG GTC TTT GGG 
CAC TGT AAT CCT -3' 
1451-1668 60.1-59.9 218 
α-1B 100071055 XR_044650.1 
5'- AAC CAG ACC TCG 
AGC AAT TCC ACA -3' 
5'- GCC AAC ACA AGA 
TGA ACA TGC CGA -3' 
205-1042 60.3-60.0 838 
α-1D 100066003 XR_044537.1 
5'- ACC TGC AGA CGG 
TCA CCA ACT ATT -3' 
5'- TCC GTC ATG ATG 
GCA GGG TAC TTT -3' 
641-893 60.0-60.0 253 
α-2B 100051684 NM_001164012.1 
5'- ACC CTG CCT CAT 
CAT GAT CCT TGT -3 
5'- ACC CAG GCT GTA 
GCT GAA GAA GAA -3' 
549-1194 59.9-59.7 646 
Serotonergic         
5-HTR1B 100009680 NM_001081779.1 
5'- AAG CCG AGG AAG 
AAG TGT TGG ACT -3' 
5'- GCC AAC ACA CAA 
TAA ACG CTC CCA -3' 
572-982 60.0-60.0 411 
5-HTR1D 100071630 XM_001501440.1 
5'- CAA CGC CTT TGT 
GCT TAC CAC CAT -3 
5'- AAT GAC ACA GAG 
GTG CAG GAT GGA -3' 
165-396 60.0-60.0 232 
5-HTR2A 100009685 NM_001081784.1 
5'- ACT CCA GAA CCA 
GGG CAT TTC TGA -3' 
5'- AAG AAG CTA ATT 
TGG CCC GTG TGC -3' 
560-841 60.0-60.1 282 
5-HTR2B 100057052 XM_001498084.1 
5'- ACT GGC TGC CTT 
CTT TAC ACC TCT -3' 
5'- TTG TGA GAA CCA TCC 
AGC ATT GCC -3' 
703-903 59.9-59.7 201 
5-HTR4 100034053 NM_001163982.1 
5'- CCC TTT GGT GCC 
ATT GAG TTG GTT -3' 
5'- AGC GTT CAT CAT CAC 
AGC AGA GGA -3' 
264-1041 60.0-60.0 778 
5-HTR7 100009688 XM_001501255.2 
5'- AAG TTG TGA TCG 
GCT CCA TCC TGA -3 
5'- GTT TGC ATA GCC 
CAG CCA CAG AAA -3' 
494-1383 59.9-59.9 890 
Dopaminergic        
DRD1 100058846 XM_001916862.1 
5'- ACA TCA TGT GCT 
CCA CTG CGT CTA -3' 
5'- AGG AGC TTT CGG 
GTT GAG AAC ACT -3' 
308-778 60.0-60.0 471 
DRD2 100062195 XM_001501996.2 
5'- ACA CAG ACC AGA 
ACG AGT GCA TCA -3' 
5'- TGG GCA TGG ACT 
GGA TCT CAA AGA -3' 
530-1051 60.1-59.8 522 
DRD3 100061160 XM_001917412.1 
5'- TCA CTA CCA ACA 
TGG CAC TGG ACA -3' 
5'- TCG ACA ACC TGC CGT 
TAC TGA GTT -3' 
408-922 60.1-60.0 515 
DRD4 100147552 EF012228.1 
5'- AGG AAA GCT GCT 
TAG GTC TCG GTT -3' 
5'- TCA GCC TGT TAA CCT 
GTC ACT GCT -3' 
829-1255 59.9-60.0 427 
DRD5 100069604 XM_001917813.1 
5'- TCA TGA TCG TAA 
CCT ACA CGC GCA -3' 
5'- ACG GGA CCA TGC 
AGT TAA GGA TGA -3' 
713-955 60.0-60.0 243 
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Table 4.1 (continued) 
Receptor Gene ID # Accession Number Forward Primer Reverse Primer Location Annealing Temperature PCR Product (bp) 
Other        
PGR 100033883 AF053141 
5'- ACT ACG TTG TGG 
AGA ATG GGC TGT -3' 
5'- ACA GGT GTT GAA TTT 
GGC TGG ACC -3' 
164-586 60.0-59.7 423 
ER α 791249 AF007799.1 
5'- TTC TGG AAT GTG 
CCT GGC TAG AGA -3' 
5'- AGA CTT CAG GGT 
GCT GGA CAG AAA -3' 
19-290 59.5-59.9 272 
ER β 100033964 AJ439894.1 
5'- TGC TGA TGG TGG 
GCC TGA TAT G -3' 
5'- AGG ATC ATG GCC 
TTG ACA CAG AGA -3' 
62-263 59.1-59.6 202 
Control        
GAPDH 100033897 AF083897.1 
5'- ATC ATC CCT GCT 
TCT ACT GGT GCT -3' 
5'- ACA AAG TGG TCG 
TTG AGG GCA ATG -3' 
71-378 59.6-59.8 308 
AFP 100034185 U28947.1 
5'- TTA CTG GCA CGC 
AAG AAG GAC TCT -3' 
5'- TCC TAA TTT CTG GAA 
GAG GCC GCA -3' 
399-1295 60.0-60.0 897 
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Table 4.2. List of primers used to amplify equine-specific nucleotide sequences within isolated palmar artery, palmar vein, and uterine 
artery vessels for Experiment 2. 
Receptor Gene ID # Accession Number Forward Primer Reverse Primer Location Annealing Temperature PCR Product (bp) 
Serotonergic        
5-HTR1B 100009680 NM_001081779.1 
5'- ACG TGA ACC AAG TCA 
AAG TGC GAG -3' 
5'- AGG GCA GCC AAC 
ACA CAA TAA ACG -3' 
857-988 59.5-60.0 132 
5-HTR1D 100071630 XM_001501440.1 
5'- TGG CCA CGA CTG ACC 
TCT TAG TTT -3' 
5'- AAT GAC ACA GAG 
GTG CAG GAT GGA -3' 
239-396 59.8-60.0 158 
5-HTR2A 100009685 NM_001081784.1 
5'- ACT CCA GAA CCA GGG 
CAT TTC TGA -3' 
5'- ACC TTG GAA TCA TCC 
TGT AGC CCA -3' 
560-662 60.0-59.7 103 
5-HTR2B 100057052 XM_001498084.1 
5'- ACT GGC TGC CTT CTT 
TAC ACC TCT -3' 
5'- CGT TAG GCG TTG 
AGG TGG TTT GTT -3' 
703-817 59.9-59.6 115 
5-HTR7 100009688 XM_001501255.2 
5'- ATA TGC CTT CTT CAA 
CCG GGA CCT -3' 
5'- TCT CAG CAA GCT TCA 
GAG CCT CAT -3' 
1404-1525 59.9-59.9 122 
Control        
GAPDH 
100033897 AF083897.1 
5'- ATC AAG AAG GTG GTG 
AAG CAG GCA -3' 
5'- ACA AAG TGG TCG 
TTG AGG GCA ATG -3' 
227-378 60.6-59.8 152 
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Experiment 1 
To minimize the evaluation of gene expression for unexpressed receptor genes, 
Experiment 1 determined which of the genes were present in the transcriptome of the 
isolated vessels. Four controls were used throughout this experiment: a negative primer 
control, a positive primer control, a positive tissue control, and a no template control. 
Alpha-fetoprotein (AFP) was used as a negative primer control. Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) was used as a positive primer control (reference 
gene) against a pooled sample homogenate. A pooled sample of heart, kidney, 
hypothalamus, and pituitary tissues were collected and used as a positive tissue control. 
Gene amplification was performed using the Taq polymerase (5prime, Cat. No 2200310) 
amplification protocol (Appendix H) and cDNA obtained from the sample vessels. Upon 
removal from the thermal cycler (Eppendorf Mastercycler ep Gradient S), samples were 
transferred to an electrophoresis gel (100 ml 1x TAE, 1.5g agarose, 2μl ethidium 
bromide), allowed to run for 20 minutes at 100 volts, and PCR product bands were 
visualized using a Kodak Gel Logic 6000 PRO image system.    
 
Experiment 2 
Experiment 2 was a semi-quantitative expression analysis of serotonin (5-
hydroxytryptamine, 5-HT) receptors subtypes 1B, 1D, 2A, 2B, and 7,  within the 
transcriptome of the isolated vessels (Table 2). Relative abundance of serotonergic 
receptor mRNA and GAPDH mRNA were determined using semi-quantitative real-time 
PCR performed on an ABI 7000 Sequence Detection System (Applied Biosystems, 
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Roster City, CA). Gene amplification was completed using SYBR Green (Applied 
Biosystems, Cat. No. 4309155) amplification protocol (Appendix I). Quantitation of 
serotonergic mRNA expression was conducted using the relative standard curve method 
(Applied Biosystems Inc., 2008) with expression normalized to GAPDH mRNA 
expression. The standard curve for each gene was generated from a pooled homogenate 
of all experimental tissues, which was serially diluted 1-fold, 2-fold, 4-fold, 8-fold, 1000-
fold, and 10,000-fold.  
 
Statistical Analyses 
Expression data generated in Experiment 2 were analyzed using Mixed Models of 
SAS, version 9.2 (SAS Institute, 2010). Fixed effects were vessel, receptor, and the 
interaction of vessel*receptor. These effects were evaluated as a completely randomized 
design, with the model statement shown in Model 4.1 (Appendix J). Significance of main 
effects and the interaction were determined using the F test within ANOVA. Normal 
distribution of the data was evaluated using the Shapiro-Wilk's test in the Univariate 
procedure of SAS. Mean separations were conducted on significant interactions using the 
LSD feature in SAS and comparisons with a P-value less than 0.05 were considered 
significant.  
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Results 
 
Experiment 1 
Among all the different genes evaluated, only DRD2, DRD3, and 5-HTR4 were 
determined to be absent across all vessels measured (Table 4.3). Of the genes chosen for 
inclusion in Experiment 1, the equine-specific nucleotide sequences for ADRα-1D and 
ADRα-2B – which were predicted using BLAST – produced primers which yielded 
unreliable results. Attempts to reconcile this led to the discovery that following the 
initiation of this experiment the ADRα1D and ADRα2B  published equine-specific gene 
sequences (used to construct primers for Experiment 1) had been removed from the 
NCBI database. This resulted in the removal of these two genes from the study.  Presence 
of a gene within the transcriptome was defined as the ability of the primer for that gene to 
amplify at least 75% of the samples that were tested against it (Figure 4.1). Results from 
Experiment 1 revealed a large group of serontonergic receptors expressed within the 
transcriptome of equine PA, PV, and UA. Because the group of serotonin receptors was 
sequenced and expressed more completely, they were chosen for quantitation in 
Experiment 2.  
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Table 4.3. Genes detected, not detected, or removed in Experiment 1.  
Detected Not Detected Removed 
Adrenergic Dopaminergic Adrenergic 
α-1A DRD2 α-1D 
α-1B DRD3 α-2B 
Serotonergic Serotonergic  
5-HTR1B 5-HTR4  
5-HTR1D   
5-HTR2A   
5-HTR2B   
5-HTR7   
Dopaminergic   
DRD1   
DRD4   
DRD5   
Other   
PGR   
ER α   
ER β   
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Experiment 2 
The main effect of vessel type was significantly different in relative quantity of 
total serotonergic receptor mRNA (P < 0.0001). The main effect of receptor was 
significant as well (P < 0.0001). All serotonergic receptor subtype mRNA's were 
detected, but only receptor 5-HT2B had a greater quantity of mRNA from all others tested 
(P < 0.0001), while receptor 5-HT1D tended to be greater than receptor 5-HT2A (P = 
0.0556). The interaction of vessel*receptor was significant (P < 0.0001), indicating that 
expression of receptor type differed across vessel type. Within the PA (Figure 4.2), the 5-
HTR2B gene was expressed in the greatest relative quantity (P = 0.0388), while all other 
receptors were not different. Within the PV (Figure 4.2), receptor 5-HT2A had a greater 
quantity mRNA than receptor 5-HT1B (P = 0.0104), and tended to be greater than 
receptors 5-HT1D (P= 0.0816) and 5-HT7 (P = 0.0809). Within the UA (Figure 4.2), 
receptor 5-HT2B had the greatest quantity of mRNA (P < 0.0001), while receptor 5-HT2A 
had a lower quantity of mRNA than 5-HT2B (P < 0.0001) and 5-HT1D (P = 0.0003), yet 
only tended to be lower than 5-HT1B (P = 0.0640) and 5-HT7 (P = 0.0849). 
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Figure 4.1. Example of positive results from a single biogenic amine receptor, DRD1. 
An example gel from Experiment 1 where a single biogenic amine receptor was 
evaluated (DRD1 shown). Wells 1-80 are duplicates of all 40 samples; the last three well 
duplicates are (from left to right) positive tissue control (a heart, kidney, hypothalamus, 
and pituitary tissue homogenate), no template control (no cDNA in the reaction well), 
and positive primer control (GAPDH). 
 
  
 66 
 
 
Figure 4.2. Expression of serotonergic (5HT) receptors by vessel. 
Expression of 5HT receptors was normalized to glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) using the standard curve method.  Within the PA, the 5-
HTR2B gene had the greatest relative quantity mRNA (P =0.0388). Within the PV, the 5-
HTR2A gene had a relative quantity of mRNA greater than 5-HTR1B only (P =0.0104). 
Within the UA, receptor 5-HT2B has the greatest relative quantity mRNA  (P <0.0001), 
while 5-HT2A had the lowest relative quantity mRNA (P <0.0001).  
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Discussion 
Alpha adrenoreceptors – and not beta adrenoreceptors – were the focus of 
Experiment 1 because they are known to modulate vasoconstriction. Several alpha 
adrenoreceptors – including ADRα-1D, -2A, -2B, -2C, and -2D – were not profiled 
during this experiment due to an inability to obtain reliable corresponding equine-specific 
nucleotide sequences. However, the presence of the ADRα-1A and ADRα-1B receptors 
indicates that those alpha adrenoreceptors are present in equine vasculature, and that the 
profile of adrenoreceptor subtypes within equine vasculature will need to be more 
completely explored at a later time as these genes are sequenced. Future studies involving 
all subtypes missing from this study, as well as beta adrenoreceptors, will provide a 
complete profile of all adrenoreceptors within equine vasculature. 
The presence of the DRD1-like receptors DRD1and DRD5 concurs with reports 
from other species (Jose et al., 2003; Zeng et al., 2004). However, the presence of the 
DRD2-like receptor DRD4 within equine vasculature has not previously been reported. 
Dopamine receptors have a wide distribution in the brain, and have a density 10-100 
times that of the DRD2-like receptors (Hurley and Jenner, 2006). Although it is difficult 
to extrapolate from the brain to the extremities, it is interesting to note that within the 
human brain DRD4 does not behave like the other DRD2-like receptors, and instead has 
a distribution similar to the DRD1-like receptors (Hurley and Jenner, 2006). If the 
distribution of DRD4 throughout the rest of the body is similar to its distribution within 
the brain, then it is reasonable to conclude that DRD4 will be present alongside DRD1-
like receptors in tissue where DRD1-like receptors are found.  
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Serotonin receptors 1B, 1D, 2A, 2B, and 7 were present in the tested equine 
vasculature, which concurs with a previous report (Weller et al., 1994). Similarly, 5-
HTR4 was not present in the evaluated equine vasculature, which agrees with previous 
reports of the distribution of this receptor (Hegde and Eglen, 1996). While it is not 
necessary to profile receptors which are not currently thought to be present in the 
vasculature, including such receptors validates this presence/absence study. In addition to 
demonstrating the presence of receptor subtypes already known to be present in the 
vasculature of other species (Weller et al., 1994; Rang and Dale, 2007), we have 
demonstrated the absence of receptor subtypes known to be absent in the vasculature of 
other species.   
Combining the results from Experiment 1 with Experiment 2 yields a profile 
within equine vasculature of the 5-HT receptor subtypes, which are known to play a role 
in equine peripheral vasoconstriction (Rang and Dale, 2007). The interaction of receptor 
and vessel may indicate the important receptor subtype within each vessel type. Within 
the equine PA and UA, receptor subtype 5-HT2B had the greatest expression level of 
mRNA (P < 0.0001). Serotonergic receptor 2B in mice has been shown to be important in 
regulating vascular structure and function (Nebigil et al., 2001). There is also evidence in 
mice that 5-HT2B is important in controlling plasma serotonin levels.  
Serotonergic receptor 2A is often mentioned alongside 5-HT2B as being widely 
distributed throughout vascular epithelium and smooth muscle, where they induce 
vasoconstriction (Oyama and Levy, 2010). Interestingly, although relative quantities of 5-
HT2B were significantly different among vessel types, with 5-HT2B relative quantities in 
the PV being the lowest, relative quantities of 5-HT2A were not significantly different 
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between vessels. Thus, it seems that while 5-HT2A is expressed at lower quantities in 
other vessels (relative to other receptors), it is slightly increased in the PV. In addition to 
its known vasoconstrictive effects, 5-HT2A has known effects in the brain, including the 
mediation of elevated plasma levels of oxytocin, ACTH, and corticosterone (Zhang et al., 
2002). In the peripheral vasculature, 5-HT2A is also known to play a role in suppressing 
TNF-α-mediated inflammation (Yu et al., 2008).  
The differences in relative quantity of receptor subtypes across vessels may be 
readily explained by understanding their physiological roles in response to environmental 
stimuli. Uterine arteries, for instance, must be responsive to normal physiological 
changes which may come about due to pregnancy or normal cyclicity. When the uterine 
arteries of non-pregnant mares were observed across the estrous cycle and at first 
detectable pregnancy using Doppler ultrasound, the time-averaged mean velocity and 
resistivity index significantly changed at first detectable pregnancy (Bollwein et al., 
2003), and at different days of the estrous cycle (Bollwein et al., 1998). Vessels in the 
lower limb, in addition to perfusing peripheral tissues, must aid in overall 
thermoregulation, as contractility will be altered in response to changes in ambient 
temperature (Pollitt, 1992). Recent studies further indicate that vascular reactivity is 
enhanced by reduced ambient temperatures (Zerpa et al., 2010). Thus, although an 
environmental stimulus (such as a fight or flight response) would invoke a 
vasoconstrictive response in these vessel types (Lees et al., 2004; Bernard and Barr, 
2011), the differences in relative quantity of receptor subtypes across vessels may 
emphasize the different physiological roles of those vessel types under normal 
circumstances.  
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The pharmacological differences of 5-HT, α-adrenergic, and dopaminergic 
receptors between the PA, PV, and UA components of the equine vasculature may be 
significant not only in explaining the pathogenesis of the equine vasoconstrictive 
response to fescue toxicosis, but also in explaining the lack of observed detrimental 
effects in response to this vasoconstriction. Until now, information regarding the profile 
of these receptors in the equine vasculature has been difficult to obtain. Epinephrine, 
norepinephrine, and 5-HT are potent vasoconstrictors within the equine digital 
vasculature (Elliott, 1997; Bailey and Elliott, 1998), but the precise receptor subtypes 
which are responsible for the vasoconstrictive effect of equine fescue toxicosis are still 
unknown. Furthermore, the impact of the presence of the dopaminergic receptors and the 
possible additive effect of the 5-HT and α-adrenergic receptors within the vasculature 
will need to be elucidated further. These data may aid in the identification of the biogenic 
amine receptor subtypes most potent in the vasoconstrictive effect of equine fescue 
toxicosis, and future experiments may be able to use these data to develop treatments or 
preventions for fescue toxicosis. 
In conclusion, Experiments 1 and 2 describe a profile of 5-HT, dopaminergic, and 
adrenergic receptors within the equine PA, PV, and UA transcriptomes that are known to 
play roles in equine peripheral vasoconstriction. These receptors may also play roles in 
the vasoconstrictive response of equine fescue toxicosis, a hypothesis which is supported 
by recent observations in vivo of a vasoconstrictive response to E+ tall fescue (Moore et 
al., 2008; McDowell et al., 2009). Still, this profile of receptors with constrictive 
properties is far from conclusive, and immunohistochemical analysis would aid in the 
identification of functional biogenic amine receptors in the equine vasculature. 
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Knowledge of a profile of biogenic amine receptors in the equine vasculature would aid 
future research in determining what receptors specifically interact with the ergot alkaloids 
produced by tall fescue.  
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CHAPTER FIVE: Discussion & Summary 
 
Losses attributable to fescue toxicosis likely exceed $1 billion annually, when 
economic impacts on ruminant, small ruminant, and equine industries are combined 
(Strickland, 2011). However, producers often fail to recognize problems with fescue 
toxicosis as many of the signs are not overtly severe and have the potential to go 
undetected. This is especially true for horses, as many fescue toxicosis signs not 
associated with the pregnant mare are not consistently reported. Signs such as heat 
intolerance, decreased growth rates, and decreased fertility are perhaps inconsistently 
reported because of the toxin load variability between studies coupled with an unknown 
baseline toxicity level at which harmful signs begin to be observed in animals ingesting 
endophyte-infected (E+) tall fescue. Therefore, an effort to improve repeatability must 
include a method of assessing a baseline toxicity level in animals ingesting E+ tall fescue. 
Possible methods of assessing a baseline toxicity level in animals ingesting E+ 
tall fescue include measurements of blood concentrations of ergot alkaloids, 
measurements of ergot alkaloid metabolites in excrement, and measurement of ergot 
alkaloid concentration intake. Such measurements are not without error (see literature 
review), however, and investigators risk performing whole experiments without reaching 
a baseline toxicity level in treatment animals. Recent reports from this lab (Moore et al., 
2008; McDowell et al., 2009) provide a model for a real-time measurement of the signs 
of fescue toxicosis in an animal exposed to E+ tall fescue by way of Doppler 
ultrasonography of the palmar artery (PA), dubbed the McDowell Model. This model 
substantiates and expands upon earlier reports (Abney et al., 1993) of the constrictive 
potential of ergot alkaloids in equine vasculature, and the possibility of measuring that 
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constriction in vivo using Doppler ultrasound (Aiken et al., 2007). Therefore, the 
McDowell Model may be able to provide investigators with a satisfactory real-time 
bioassay for determining the premonitory signs of fescue toxicosis in an individual 
exposed to E+ tall fescue.  
Experiments from Chapters 3 & 4 were performed with the overall objective of 
exploring the effect of fescue toxicosis on certain parameters of the estrous cycle, 
including differences in interovulatory interval, serum concentrations of PRL, P4, and 
E2, and blood flow to the corpus luteum (CL). This thesis also aimed to strengthen, 
substantiate, and expand upon the previous reports which used Doppler ultrasound to 
assess vasoconstriction in the PA of treatment animals (Moore et al., 2008; McDowell et 
al., 2009). Taken together, Chapters 3 & 4 explored the effect that vasoconstriction plays 
in the equine response to fescue toxicosis. 
Implications from Chapter 3 suggest that the effects of E+ tall fescue on 
parameters of cyclicity, serum concentrations of progesterone (P4), and blood flow may 
not differ when mares consume an average of 10 mg ergovaline + ergovalinine/day. Use 
of the McDowell Model to assess vasoconstriction in the PA and PV revealed that 
vasoconstriction was significantly increased in mares ingesting E+ tall fescue, as 
measured by the PA and PV lumen diameter, and the PA area, circumference, and RI. 
This indicates that the model is successful in providing a real-time bioassay of exposure 
to E+ tall fescue in horses, and as a biomarker of fescue toxicosis in non-pregnant mares 
is perhaps even more sensitive than serum concentrations of PRL. Of interest, however, is 
that alterations in interovulatory interval in mares ingesting E+ tall fescue seed did not 
agree with those of Brendemuehl et al (1994). This suggests that while a treatment effect 
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was reached in treatment mares, as confirmed by Doppler ultrasonography of the PA and 
PV, a maximal toxic effect may not have been reached. Thus, future studies employing 
the McDowell Model may wish to explore a scale in which toxicity is graded based on 
vasoconstriction. This again demands the establishment of a baseline level of toxicity. 
Experiments to determine a minimal level of ergot alkaloid exposure needed to cause PA 
vasoconstriction are underway (K. J. McDowell, Personal Communication). 
Results from Chapter 4 suggest that the vasoconstriction observed in the PA and 
PV when horses ingest E+ tall fescue may be due to the agonistic action of ergot 
alkaloids on serotinergic and α-adrenergic receptors. Also, results from Chapter 4 
reported that 5-HT 1B, 1D, 2A, 2B, and 7, dopamine receptors 1, 4, and 5, and α-
adrenergic receptors 1A and 1B were present in the equine PA, PV, and UA, while only 
dopamine receptors D2 and D3, and 5-HT4 were absent from the equine PA, PV, and UA. 
The presence of the type-1 like dopamine receptors will need to be explored further.  
In Experiment 2 from Chapter 4, results from real time-PCR indicate that 
serotinergic receptors are present in the uterine artery in greater relative abundance than 
in either the PA or PV. Such a presence of receptors with vasoconstrictive potential could 
indicate an as of yet unobserved vasoconstriction in the equine response to fescue 
toxicosis. Research is underway which incorporates an investigation of the 
vasoconstriction of the uterine artery when elucidating the equine response to fescue 
toxicosis (McDowell et al., 2012). 
Combined results from Chapters 3 & 4 indicate that the increased sensitivity of 
the PA relative to the PV may be due to the greater relative abundance of serotonergic 
receptors in the PA as compared to the PV. This combination of experiments may aid 
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future research in determining what receptors specifically interact with tall fescue 
alkaloids. In future whole animal research, this information may be relevant when 
comparing responses in the PA vs. PV, and may have a pertinent bearing on the 
development of Doppler ultrasonography as a tool for the diagnosis of an individual's 
exposure to E+ tall fescue. Further research is needed, however, to fully quantify the 
disparities in vasoconstriction between the PA and PV. 
In Summary, observations from Chapters 3 & 4 indicate that there is no alteration 
of interovulatory intervals in mares ingesting E+ tall fescue seed. Additional observations 
of the PA and PV indicate that horses have a significant vasoconstrictive response to E+ 
tall fescue. This response is confirmed by the presence of dopaminergic, serotinergic, and 
α-adrenergic receptors as confirmed by PCR. Future studies may wish to further 
characterize the relationship between the profile of biogenic amine receptor subtypes 
reported in Chapter 4 and the in vivo vasoconstrictive response observed in Chapter 3. 
Measurement of vasoconstriction using the McDowell Model may be of use as a bioassay 
of fescue toxicity in non-pregnant mares, and may also be used to establish baseline and 
maximal levels of toxicity in the horse. In addition, a full profile of dopaminergic, 
serotinergic, and α-adrenergic receptors should include the full range of serotinergic and 
α-adrenergic receptors as better genetic materials become available, and 
immunohistochemical staining may be preferable in order to confirm that mRNA is being 
converted to protein.  
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Appendices  
 
Appendix A: Composition of feed concentrate used in Chapter 3 
 
Feed Type Manufacturer Part in Mixture 
Sweet Feed, Performance 13 Woodford Feed  1/3 
Pellet, UK Custom Mix Farmers Feed Mill, Inc.  1/3 
Race Horse Oats Farmers Feed Mill, Inc.  1/3 
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Appendix B: Model statements used for statistical analysis of data from Chapter 3 
 
Model 3.1: 
 Yijkl = μ + δl + βi(l) + αj + γk + λr(lk) + εijkl 
We assume the following: 
1.  Yijkl is the response due to subject i, treatment j, and period k, and sequence l. 
2.  μ  is an overall mean. 
3.  δl is a fixed effect due to sequence l; Σ δl = 0, l=1,2. 
4.  βi(l) is a random effect due to subject i nested within sequence l; assume βi(l) iid, ~ N(0, 
σ2β), i=1,...12. 
5.  αj  is a fixed effect due to treatment j; Σ αj = 0, j=1,2. 
6.  γk is a fixed effect due to period k; Σ γk = 0, k=1,2. 
7.  εijkl is the random error; assume εijkl iid, ~ N(0, σ2ε). 
 
Model 3.2: 
Yijklm = μ + δl + βi(l) + αj + γk + τm +  ταmj  + τγmk + τδml + εijklm 
We assume the following: 
1.    Yijkl is the response due to subject i, treatment j, and period k, and sequence l. 
2.     μ  is an overall mean. 
3.    δl is a fixed effect due to sequence l; Σ δl = 0, l=1,2. 
4.    βi(l) is a random effect due to subject i nested within sequence l; assume βi(l) iid, ~ 
N(0, σ2β), i=1,...12. 
5.    αj  is a fixed effect due to treatment j; Σ αj = 0, j=1,2. 
6.    γk is a fixed effect due to period k; Σ γk = 0, k=1,2. 
7.    τm  is a fixed effect due to time l; Σ τm = 0. 
8.    ταmj is a fixed interaction effect due to time m and treatment j; Σ ατjm = 0. 
9.    τγmk is a fixed interaction effect due to time m and period k; Σ αγjk = 0 
10.  τδml is a fixed interaction effect due to time m and sequence l; Σ τδml = 0 
11.  εijklm is the random error; assume εjkm iid, ~ N(0, σ2ε). 
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Appendix C:TRIzol ® Reagent (Invitrogen, Cat. No. 15596-018) isolation protocol 
1. Homogenize tissue samples in 1ml TRIzol ® Reagent per 50-100 mg tissue. The 
sample volume should not exceed 10% of the bolume of TRIzol ® Reagent used 
for homogenization 
2. Incubate the homogenized samples for 5 minutes at 15-30 ⁰C to permit the 
complete dissociation of nucleoprotein complexes  
a. Add 0.2 ml of chloroform per 1 ml of TRIzol ® Reagent 
b. Cap samples, and shake vigorously by hand for 15 seconds 
c. Incubate at 15-30 ⁰C for 2-3 minutes, then centrifuge the samples at no 
more than 12,000xg for 15 minutes at 2-8 ⁰C 
d. Following centrifugation, the mixture separates into a lower red, phenol-
chloroform phase, an interphase, and a colorless upper aqueous phase. 
RNA remains exclusively in the aqueous phase 
3. Transfer the aqueous phase to a fresh tube, discarding the old tube 
a. Precipitate the RNA from the aqueous phase by mixing with isopropyl 
alcohol. Use 0.5ml isopropyl alcohol per 1ml TRIzol ® Reagent used.  
b. Incubate samples at 15-30 ⁰C for 10 minutes, then centrifuge at no more 
than 12,000xg for 10 minutes at 2-8⁰C. 
c. The RNA precipitate forms a gel-like pellet on the side and bottom of tube 
4. Remove the supernatant.  
a. Wash the pellet once with 75% ethanol, adding at least 1 ml of 75% 
ethanol per 1 ml TRIzol® Reagent used for the initial homogenization 
b. Mix the sample by vortexing, then centrifuge at no more than 7,500xg for 
5 minutes at 2-8⁰C 
5. At the end of the procedure, remove the supernatant, leaving only the pellet.  
a. Briefly dry the RNA pellet (air- or vacuum-dry for 5-10 minutes) 
b. It is important not to let the RNA pellet dry completely, as this decreases 
solubility greatly 
c. Dissolve RNA pellet in 50 μl of RNase-free water 
d. Store at -80⁰C for further use 
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Appendix D: RNeasy RNA Cleanup Kit (QIAGEN, Cat. No. 74104) protocol 
1. Adjust the sample to a volume of 100 μl with RNase-free water. Add 350 μl of 
Buffer RLT, and mix well 
2. Add 250 μl ethanol (96-100%) to the diluted RNA, and mix well by pipetting.  Do 
not centrifuge. Proceed immediately to step 3. 
3. Transfer the sample (700 μl) to an RNeasy Mini spin column placed in a 2 ml 
collection tube. Close the lid gently, and centrifuge for 15 s at ≥8000xg. Discard 
the flow-through. 
4. Add 500 μl Buffer RPE to the RNeasy spin column. Close the lid gently, and 
centrifuge for 15 s at ≥8000xg to wash the spin column membrane. Discard the 
flow-through. 
5. Add 500 μl Buffer RPE to the RNeasy spin column. Close the lid gently, and 
centrifuge for 2 min at ≥8000xg to wash the spin column membrane 
a. Note: After centrifugation, carefully remove the RNeasy spin column from 
the collection tube to that the column does no contact the flow-though. 
Otherwise, carryover of ethanol will occur 
6. Optional: place the RNeasy spin column in a new 2ml collection tube, and discard 
the old collection tube with the flow through. Close the lid gently, and centrifuge 
at full speed for 1 minute. 
7. Place the RNeasy spin column in a new 1.5 ml collection tube. Add 30-50 
μlRNase-free water directly to the spin column membrane. Close the lid gently, 
and centrifuge for 1 minute at ≥8000xg to elute the RNA. 
8. If the expected RNA yield is >30 μg, repeat step 7 using another 30-50 μl RNase-
free water, or using the eluate from step 7. 
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Appendix E: Experion RNA StdSens Analysis Kit (Bio-Rad laboratories Inc., Cat. No. 
700-7106) procedure 
1. Preparing the gel stain 
a. Remove the RNA gel, RNA stain, and loading buffer from storage and 
allow them to equilibrate to room temperature for ~15 minutes. Keep the 
RNA stain protected from light. 
b. Briefly vortex the RNA stain (blue cap) and spin down in a 
microcentrifuge for 3-5 seconds. Make sure the DMSO in the stain is 
completely thawed. 
c. Pipet 600 μl RNA gel (green cap) into a spin filter tube. 
d. Centrifuge the gel at 1,500xg for 10 minutes. Confirm that all of the get 
has passed through the filter, and then discard the filter. 
e. Pipet 65 μl filtered gel into an RNase-free microcentrifuge tube. Add 1 μl 
RNA stain to the tube. Briefly vortex the solution. Keep the gel-stain (GS) 
solution protected from light. 
f. Cap the RNA stain tightly, since the DMSO is highly hygroscopic, and 
store it in the dark. Gel-stain solution should be used within the week. 
2. Preparing the samples and RNA ladder 
a. Remove the RNA ladder (red cap) from storage and allow it to thaw on 
ice. 
b. Determine the amount of RNA ladder required. A total of 1 μl RNA ladder 
is required for each chip. Add 2 μl RNA ladder to account for evaporation 
during the heat denaturation step 
c. Pipet a minimum of 3 μl RNA ladder into an RNase-free microcentrifuge 
tube. 
d. Prepare all samples by pipetting at least 3 μl sample into an RNase-free 
microcentrifuge tube. 
e. Denature the ladder and samples for 2 minutes at 70⁰C. 
f. Cool the denatured ladder and samples by immediately placing the tubes 
on ice for 5 minutes. 
g. Spin down the ladder and samples in a microcentrifuge for 3-5 seconds. 
Store on ice until used. 
3. Priming the chip 
a. Open the Experion priming station by pressing down on the front lever.  
b. Remove an Experion RNA StdSens chip out of its packaging and place it 
on the chip platform, matching the arrow on the chip with the alignment 
arrow on the chip platform. A post on the chip prevents insertion in the 
wrong position. Do not force the chip into position. 
c. Pipet 9 μl filtered get-stain solution into the well labeled GS. Insert the tip 
of the pipet vertically and to the bottom of the well when dispensing. Do 
not expel air at the end of the pipetting step. 
d. Carefully close the priming station by gently pressing down on the front 
lever. The lid should snap completely closed. 
 81 
 
e. Set the pressure setting to B and the time setting to 1, as specified by the 
alphanumeric code on the chip. 
f. Press the start button. The “Priming” message will illuminate on the LCD 
screen, the priming station will pressurize, and the timer will count down. 
Complete priming requires approx. 30 seconds. An audible signal 
indicates that priming is complete, and a “Ready” message will be 
displayed. Open the priming station by pressing down on the release lever. 
g. Turn the chip over and inspect the microchannels for bubbles or evidence 
of incomplete priming. The glass chip will appear opaque and the 
microchannels will be difficult to see if they are primed properly. 
h. Place the chip on a clean surface for loading samples. 
4. Loading the samples and the RNA ladder into the chip 
a. Pipett 9 μl of the gel-stain solution into the other well labeled GS.  
b. Pipet 9 μl of filtered gel into the well labeled G. 
c. Vortex the loading buffer (yellow cap) before use. 
d. Pipet 5 μl of the loading buffer in each sample well (1-12) and the ladder 
well, labeled L. 
i. Make sure that the pipet tip is centered and positioned vertically all 
the way to the bottom of the well. This will aid in avoiding 
introducing bubbles into the sample wells. 
ii. All wells should be filled with the loading buffer, even when fewer 
than 12 samples are run.  
iii. Use a new pipet tip for each delivery to prevent contamination of 
the loading buffer stock.  
e. Pipet 1 μl denatured RNA ladder into the well lableled L.  
i. Every chip must have the RNa ladder loaded into the ladder well 
for accurate quantitation of samples. 
f. Pipet 1 μl sample into each of the 12 sample wells. 
g. If running fewer than 12 samples, add 1 μl loading buffer, TE buffer, or 
DEPC-treated water to the unused sample well(s). 
h. Place the chip in the Experion vortexing station. 
i. Turn on the vortexer, which will operate for 60 seconds and then 
automatically shut off. Remove the chip when the vortexer stops. 
j. Start the run immediately to prevent excessive evaporation and poor 
results or a chip performance error. 
5. Running the RNA analysis 
a. Turn on the power to the Experion electrophoresis station by pushing the 
green button in the center of the front panel. The steady green LED above 
the button indicates that the unit is on. 
b. Launch the Experion software. 
c. Open the lid of the electrophoresis station. Place the primed chip, which 
has been loaded with samples, on the chip platform. Ensure that the chip is 
seared properly and then carefully close the lid. 
d. Select new run. Select the RNA StdSens protocol. 
e. Click the start button to begin the chip run. 
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f. After a run has started, the green LED in the center of the front panel on 
the electrophoresis station will begin blinking. 
g. When the chip run is complete, a “Run Complete” message will be 
displayed. Remove the chip from the electrophoresis station and dispose 
of it properly. To prevent contamination of the electrodes, do not leave the 
chip in the electrophoresis station for an extended period of time. 
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Appendix F: TURBO DNA-free ™ DNase Treatment (Applied Biosystems, Part No 
AM1907) protocol 
1. Add 0.1 volume 10X TURBO DNase Buffer and 1 μl TURBO DNase to the 
RNA, and mix gently 
a. For routine DNase treatment (≤200 μl nucleic acid per ml), use 1 μl 
TURBO DNase (2 U) for up to 1 μg of RNA in a 50 μl reaction.  
2. Incubate at 37⁰ C for 20-30 minutes 
3. Add resuspended DNase Inactivation Reagent (typically 0.1 volume) and mix 
well 
a. For routine DNase treatment, use 2 μl or 0.1 volume DNase Inactivation 
Reagent, whichever is greater. 
4. Incubate 5 minutes at room temperature, mixing occasionally 
5. Centrifuge at 10,000xg for 1.5 minutes and transfer the RNA to a fresh tube 
a. RNA will be in the supernatant. Centrifugation pellets the DNase 
Inactivation Reagent. Avoid introducing the DNase Inactivation reagent 
into the solution.  
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Appendix G: AccuScript High Fidelity 1st Strand cDNA Synthesis Kit (Agilent 
Technologies, Cat. No. 200820) protocol for Reverse Transcriptase-Mediated 
Polymerase Chain Reaction 
1. Prepare the cDNA synthesis reaction by adding the following components to a 
microcentrifuge tube in order: 
a. RNase-free water to total volume 16.5 μl 
b. 2.0 μl of AccuScript RT Buffer (10x) 
c. 1.0 μl of gene-specific primer (0.1 μg/μl) OR oligo(dT) primer(0.5 μg/μl) 
OR 3 μl of random primers (0.1 μg/μl) 
d. 0.8 μl of dNTP mix (25 mM each dNTP) 
e. x μl of RNA. The quantity of RNA depends on the RNA purity, message 
abundance, and size of the target: 
i. if total RNA, target < 2kb, then 10-100 ng 
ii. if total RNA, target > 2kb, then 200-5000 ng 
iii. if mRNA, (all targets), then 0.1-100 ng 
2. Incubate the reaction at 65 ⁰C for 5 minutes. 
3. Cool the reaction at room temperature to allow the primers to anneal to the RNA 
(approximately 5 minutes). 
4. Add the following components to the reaction, in order, for a final reaction 
volume of 20 μl: 
a. 2 μl of 100 mM DTT 
b. 1 μl of Accuscript RT 
c. 0.5 μl of RNase Block ribonuclease inhibitor (40 U/μl) 
5. If using random primers, incubate the raction at 25 ⁰C for 10 minutes to extend 
the primers prior to the 42 ⁰C synthesis step. If using oligo(dT) or gene-specific 
primers, proceed to step 6. 
6. Place the tube in a temperature controlled thermal block at 42 ⁰C and incubate the 
reaction for 60 minutes 
7. Terminate cDNA synthesis by incubating the reaction at 70 ⁰C for 15 minutes 
8. Place the completed first-strand cDNA synthesis reaction on ice for use in 
downstream applications. If performing RT-PCR, proceed to the PCR 
amplification protocol.  
9. For long term storage, place the reaction at -20 ⁰C. 
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Appendix H: Taq Polymerase (5prime, Cat. No 2200310) amplification protocol 
1. Prepare the reaction by adding the following components to sterile thin-walled 
PCR tubes in order: 
a. 13.75 μl nuclease-free water 
b. 0.5 μl forward primer (0.1ng/μl) 
c. 0.5 μl reverse primer (0.1ng/μl) 
d. 2.5 μl 10x Mg Buffer 
e. 2.5 μl dNTP mix (25mM each dNTP) 
f. 0.25 μl Taq polymerase 
g. 5.0 μl cDNA 
2. Place the reaction into a thermocycler at the following program: 
a. 94 ⁰C for 2.00 minutes 
b. 94 ⁰C for 0.2 minutes, then 56 ⁰C for 0.1. minutes, then 65 ⁰C for 0.35 
minutes 
c. Repeat above 35 times 
d. 65 ⁰C for 1.00 minutes 
e. 4 ⁰C for holding temperature 
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Appendix I: SYBR ® Green (Applied Biosystems, Cat. No. 4309155) real time-PCR 
protocol 
1. Prepare the reaction by adding the following components to an optical 96-well 
plate in order: 
a. 7.0 μl nuclease-free water 
b. 1.5 μl forward primer (5 μM)  
c. 1.5 μl reverse primer (5 μM)  
d. 12.5 μl SYBR ® Green Master Mix 
3. Place the reaction into a thermocycler at the following program: 
a. 94 ⁰C for 2.00 minutes 
b. 94 ⁰C for 0.2 minutes, then 56 ⁰C for 0.1. minutes, then 65 ⁰C for 0.35 
minutes 
c. Repeat above 35 times 
d. 65 ⁰C for 1.00 minutes 
e. 4 ⁰C for holding temperature 
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Appendix J: Model statement for the statistical analysis of data in Experiment 2 of 
Chapter 4  
 
Model 4.1: 
Yij = μ + Vi + Rj + V*Rij + εij 
Where: 
1.  Yij is the relative quantity of receptor j within vessel i  
2.  μ is the overall mean 
3.  Vi is the fixed effect due to vessel; i=1,...40. 
4.  Rj is the fixed effect due to receptor; j=1,...5. 
5.  V*Rij is the interaction of vessel and receptor. 
6.  εij is the random error term; assume εij iid, ~ N(0, σ2ε). 
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